,IndCode,IndName
0,AIR_10,Ambient air pollution  attributable DALYs per 100'000 children under 5 years
1,AIR_11,Household air pollution attributable deaths
2,AIR_12,Household air pollution attributable deaths in children under 5 years
3,AIR_15,Household air pollution attributable DALYs
4,AIR_16,Household air pollution attributable DALYs in children under 5 years
5,AIR_17,Household air pollution attributable DALYs (per 100 000 population)
6,AIR_39,"Household air pollution attributable DALYs (per 100 000, age-standardized)"
7,AIR_4,Ambient air pollution attributable deaths in children under 5 years
8,AIR_41,Ambient air pollution attributable deaths
9,AIR_42,"Ambient air pollution attributable death rate (per 100 000 population, age-standardized)"
10,AIR_43,Ambient air pollution attributable DALYs
11,AIR_44,DALYs attributable to ambient air pollution (age-standardized)
12,AIR_45,Ambient air pollution attributable YLLs
13,AIR_46,YLLs attributable to ambient air pollution (age-standardized)
14,AIR_5,Ambient air pollution attributable death rate (per 100 000 population)
15,AIR_51,Household air pollution attributable death rate (per 100 000 population)
16,AIR_52,"Household air pollution attributable death rate (per 100 000 population, age-standardized)"
17,AIR_6,Ambient air pollution  attributable deaths per 100'000 children under 5 years
18,AIR_7,Ambient air pollution attributable DALYs
19,AIR_8,Ambient air pollution attributable DALYs  in children under 5 years
20,AIR_9,Ambient air pollution attributable DALYs  (per 100 000 population)
21,AIR_90,"Ambient air pollution attributable DALYs  (per 100 000 population, age-standardized)"
22,AMRGLASS_COORD01,Functioning national AMR surveillance plan
23,AMRGLASS_COORD02,Establishment of National Coordination Centre (NCC)
24,AMRGLASS_COORD03,Nomination of National Focal Point (NFP)
25,AMRGLASS_COORD04,Establishment of national reference laboratory (NRL)
26,AMRGLASS_QA01,EQA provided to the national reference laboratory (NRL)
27,AMRGLASS_QA02,EQA provided for bacterial identification and AST
28,AMRGLASS_QA03,EQA provided to local laboratories participating in GLASS
29,AMRGLASS_QA04,GLASS pathogens testing covered by EQA
30,AMRGLASS_QA05,Types of AST standards followed by countries
31,AMRGLASS_SURVL01,Number of national surveillance sites in each country providing data to GLASS: hospital category
32,AMRGLASS_SURVL02,Number of National surveillance sites in each country providing data to GLASS: outpatient facility category
33,AMRGLASS_SURVL03,Number of local clinical laboratories in each country performing AST to support national AMR surveillance sites
34,anc1,Antenatal care coverage - at least one visit (in the two or three years preceding the survey) (%
35,anc15,Antenatal care coverage - at least one visit (in the five years preceding the survey) (%)
36,anc4,Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%)
37,anc45,Antenatal care coverage - at least four visits (in the five years preceding the survey) (%)
38,asfr1,Adolescent fertility rate (per 1000 women aged 15-19 years)
39,ASSISTIVETECH_METNEED,Prevalence of met need of assistive products (%)
40,BP_03,Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)
41,BP_04,Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)
42,BP_05,Mean systolic blood pressure (crude estimate)
43,BP_06,Mean systolic blood pressure (age-standardized estimate)
44,Camp_airtime,Process evaluation was employed to assess implementation
45,Camp_aud_research,Formative research was conducted
46,Camp_eval_impact,Outcome evaluation was employed to assess effectiveness
47,Camp_gov_prog,Campaign was part of a comprehensive tobacco control programme
48,Camp_mat_tested,Campaign was pre-tested
49,Camp_media_planning,Campaign utilized media planning
50,Camp_nat,At least one national mass media campaign ran during the survey period
51,Camp_news,Earned media/public relations were used to promote the campaign
52,Camp_tv_radio,Campaign aired on television and/or radio
53,carep,Children aged < 5 years with pneumonia symptoms taken to a health facility (%)
54,CaseCS,Congenital syphilis number of reported cases
55,CATARACTSURGICAL,Cataract surgical coverage of adults aged 50 and over (%)
56,CATARACTSURGICALEFFECTIVE,Effective cataract surgical coverage of adults aged 50 and over (%)
57,CC_1,Climate change attributable deaths
58,CC_2,Climate change attributable DALYs ('000)
59,CC_3,Climate change attributable deaths per 100'000 capita
60,CC_4,Climate change attributable DALYs per 100'000 capita
61,CC_5,Climate change attributable deaths ('000) in children under 5 years
62,CC_6,Climate change  attributable deaths per 100'000 children under 5 years
63,CC_7,Climate change attributable DALYs ('000) in children under 5 years
64,CC_8,Climate change  attributable DALYs per 100'000 children under 5 years
65,cci,Composite coverage index (%)
66,cci2030,Composite coverage index (%)
67,CCO_1,Poverty headcount ratio at $1.25 a day (PPP) (% of population)
68,CCO_2,Human development index rank
69,CCO_3,Gender inequality index rank
70,CHILDMORT5TO14,Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)
71,CHOLERA_0000000001,Number of reported cases of cholera
72,CHOLERA_0000000002,Number of reported deaths from cholera
73,CHOLERA_0000000003,Cholera case fatality rate
74,CM_01,Number of under-five deaths
75,CM_02,Number of infant deaths
76,CM_03,Number of neonatal deaths
77,cpmt,Contraceptive prevalence - modern and traditional methods (%)
78,csection,Births by caesarean section (in the two or three years preceding the survey) (%)
79,csection5,Births by caesarean section (in the five years preceding the survey) (%)
80,DEVICES00,Total density per 100 000 population: Hospitals
81,DEVICES01,Total density per 100 000 population: Health posts
82,DEVICES02,Total density per 100 000 population: Health centres
83,DEVICES03,Total density per 100 000 population: District/rural hospitals
84,DEVICES04,Total density per 100 000 population: Provincial hospitals
85,DEVICES05,Total density per 100 000 population: Specialized hospitals
86,DEVICES06,Availability of national standards or recommended lists of medical devices
87,DEVICES07,Types of lists recommending health technology for high burden diseases
88,DEVICES08,Total density per million population: Magnetic Resonance Imaging
89,DEVICES09,Total density per million population: Computed tomography units
90,DEVICES10,Total density per million population: Positron Emission tomography
91,DEVICES11,Total density per million population: Gamma camera or Nuclear medicine
92,DEVICES12,Total density per million population: Linear Accelerator
93,DEVICES13,Type of nomenclature system
94,DEVICES14,Use of nomenclature system
95,DEVICES15,Health technology (medical device) national policy
96,DEVICES16,Unit in the Ministry of Health responsible for the management of medical devices
97,DEVICES17,Procurement of medical devices carried out at the national level
98,DEVICES18,Availability of national list of approved medical devices for procurement or reimbursement
99,DEVICES19,"National guidelines, policies or recommendations on the procurement of medical devices"
100,DEVICES20,Availability of technical specifications of medical devices to support procurement or donations
101,DEVICES21,Total density per million population: Telecobalt Unit
102,DEVICES22,Total density per million population: Radiotherapy units
103,DEVICES23,Total density per million females aged from 50 to 69 years old: Mammography units
104,E_Group,"Enforcing bans on tobacco advertising, promotion and sponsorship"
105,E1_compliance,Compliance of ban on advertising on national TV and radio
106,E1_nat_tv_radio,Ban on advertising: National TV and radio
107,E10_compliance,Compliance of ban on promotional discounts
108,E10_promo_discounts,Ban on promotional discounts
109,E11_brand_stretching,Ban on non-tobacco goods AND services identified with tobacco brand names
110,E11_compliance,Compliance of ban on non-tobacco goods AND services identified with tobacco brand names
111,E12_brand_sharing,Ban on brand name of non-tobacco products used for tobacco product
112,E12_compliance,Compliance of ban on brand name of non-tobacco products used for tobacco product
113,E13_brand_placement,Ban on appearance of tobacco brands in TV and/or films (product placement)
114,E13_compliance,Compliance of ban on appearance of tobacco brands in TV and/or films (product placement)
115,E14_compliance,Compliance of ban on appearance of tobacco products in TV and/or films
116,E14_prod_tv_films,Appearance of tobacco products in TV and/or films
117,E14a_prod_tv_films,Ban on appearance of tobacco products in TV and/or films
118,E14b_movies_anti_tob_ads,"Requirement to present prescribed anti-tobacco ads before, during or after the broadcasting or showing of any visual entertainment media product that depicts tobacco products, use or images"
119,E15_compliance,Compliance of ban on sponsored events
120,E15_sponsored_events,Sponsored events
121,E15a_sponsorship,Complete ban on sponsorship
122,E15b_sponsor_contribution,"Ban on any form of contribution (financial or other support) to any event, activity or individual"
123,E15c_sponsor_publicity,"Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals"
124,E16_csr_promo_self,Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities
125,E17_csr_promo_others,Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility activities of the tobacco companies
126,E18_csr_anti_tobacco_media,"Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth"
127,E19_movies_anti_tob_ads,"Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images"
128,E2_intl_tv_radio,"Ban on advertising: International TV and radio (broadcast from abroad, including satellite)"
129,E21_vending_machines,Complete ban on tobacco vending machines
130,E22_subnational_exists,"Subnational bans on tobacco advertising, promotion and sponsorship"
131,E23_subnat_complete_bans_exist,"Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place"
132,E24_internet_sales_ban,Ban on internet sales of tobacco products
133,E25_ban_display_pt_of_sale,Ban on display of tobacco products at points of sale
134,E26_direct_ad_fines,Law requires fines for violations of direct advertising bans
135,E27_indirect_ad_fines,Law requires fines for violations of indirect advertising bans
136,E3_compliance,Compliance of ban on advertising on local magazines and newspapers
137,E3_nat_print,Ban on advertising: Local magazines and newspapers
138,E4_intl_print,Ban on advertising: International magazines and newspapers
139,E5_billboards,Ban on advertising: Billboards and outdoor advertising
140,E5_compliance,Compliance of ban on advertising on billboards and outdoor advertising
141,E6_compliance,Compliance of ban on advertising at point of sale
142,E6_pt_of_sale,Ban on advertising: Point of sale
143,E6b_ban_display_pt_of_sale,Ban on display of tobacco products at points of sale
144,E7_internet,Ban on advertising: Internet
145,E9_compliance,Compliance of ban on free distribution of tobacco products in the mail or through other means
146,E9_free_distrib,Ban on free distribution of tobacco products in the mail or through other means
147,EC_direct_compliance,Compliance with bans on direct advertising
148,EC_indirect_compliance,Compliance with bans on promotion and sponsorship
149,EMFLIMITELECTRIC,Electric field (kV/m)
150,EMFLIMITELECTRICLF,Electric field (kV/m)
151,EMFLIMITELECTRICRF,Electric field (V/m)
152,EMFLIMITMAGNETIC,Magnetic flux density (microT)
153,EMFLIMITPOWERDENSITY,Power density (W/m^2)
154,EMFPOWERFREQUENCY,Power frequency (Hz)
155,EMFSAR,Specific absorption rate (SAR) (W/kg)
156,EMFSTANDARD,Existence of standards
157,EMFSTATUS,Legislative status
158,FINPROTECTION_CATA_ESTIMATE_AVAILABLE,Availability of estimates on large  health expenditures as a share of total expenditure or income
159,FINPROTECTION_CATA_TOT_10_LEVEL_MILLION,"Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (millions)"
160,FINPROTECTION_CATA_TOT_10_LEVEL_SH,"Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (%)"
161,FINPROTECTION_CATA_TOT_10_POP,"Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, reported data) (%)"
162,FINPROTECTION_CATA_TOT_25_LEVEL_MILLION,"Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (millions)"
163,FINPROTECTION_CATA_TOT_25_LEVEL_SH,"Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (%)"
164,FINPROTECTION_CATA_TOT_25_POP,"Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, reported data) (%)"
165,FINPROTECTION_IMP_NP_190_LEVEL_MILLION,Total population  pushed below the $1.90 a day  poverty line by household  health expenditures (millions)
166,FINPROTECTION_IMP_NP_190_LEVEL_SH,Total population  pushed below the $1.90 a day  poverty line by household  health expenditures (%)
167,FINPROTECTION_IMP_NP_310_LEVEL_MILLION,Total population  pushed below the $3.10 a day  poverty line by household  health expenditures (millions)
168,FINPROTECTION_IMP_NP_310_LEVEL_SH,Total population  pushed below the $3.10 a day  poverty line by household  health expenditures (%)
169,FINPROTECTION_IMP_NP190_POP,Population  pushed below the $1.90 a day  poverty line by household  health expenditures (%)
170,FINPROTECTION_IMP_NP310_POP,Population  pushed below the $3.10 a day  poverty line by household  health expenditures (%)
171,FINPROTECTION_IMP_PG_190_STD,"Increase in poverty gap due to household  health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%)"
172,FINPROTECTION_IMP_PG_310_STD,"Increase in poverty gap due to household  health expenditures, expressed as a proportion of the 3.10 a-day poverty line (%)"
173,FINPROTECTION_IMPOV_ESTIMATE_AVAILABLE,Availability of estimates on impoverishment due to out-of-pocket health expenditures
174,fps,Demand for family planning satisfied - modern and traditional methods (%)
175,fpsmo,Demand for family planning satisfied - modern methods (%)
176,GBD_DALYRTAGE,"Age-standardized DALYs (per 100,000)"
177,GDO_q10x1,National regulator approval of anti-dementia medication
178,GDO_q10x1x1,Availability of generic anti-dementia medication
179,GDO_q10x1x2,Availability of at least one anti-dementia medication approved for on-label use reimbursement
180,GDO_q10x2_1AVAIL,Availability of atleast one adult hygiene products for people with dementia
181,GDO_q10x2_HOSUE,Availability of atleast one housing adjustment for people with dementia
182,GDO_q10x2_TECH,Availability of  atleast one assistive technology for people with dementia
183,GDO_q11x1,Existence of dementia national nongovernmental organization
184,GDO_q11x2x1,Dementia nongovernmental organization equipped with office
185,GDO_q11x2x2_1,Dementia nongovernmental organization office branches (Sub-national)
186,GDO_q11x2x2_2,Dementia nongovernmental organization office branches (Local)
187,GDO_q11x2x2_3,Dementia nongovernmental organization office branches (National only)
188,GDO_q11x2x3,Dementia nongovernmental organization staff primarily salaried/volunteer
189,GDO_q11x2x5,Provision of governmental funding to dementia nongovernmental organization for activities/services
190,GDO_q11x2x6,Dementia nongovernmental organization's involvement in policy development
191,GDO_q12x1,Existence of dementia carer support services
192,GDO_q12x1x1,Implementation level [national/subnational] of dementia carer support services
193,GDO_q12x1x2,Existence of dedicated resources for dementia carer support services
194,GDO_q12x1x3,Existence of implementation plan for dementia carer support services
195,GDO_q12x2_2,Existence of psycho-social supports for dementia carers
196,GDO_q12x2_3,Existence of respite care for dementia carers
197,GDO_q12x2_4,Existence of information on legal rights for dementia carers
198,GDO_q12x2_5,Existence of financial benefits/social protection for dementia carers
199,GDO_q12x2x1x1_1,"Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas]"
200,GDO_q12x2x1x1_1NGO,Majority provider of dementia carer training and education (NGO)
201,GDO_q12x2x1x1_1PRV,Majority provider of dementia carer training and education (Private sector)
202,GDO_q12x2x1x1_1PUB,Majority provider of dementia carer training and education (Public sector)
203,GDO_q12x2x1x1_2,"Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]"
204,GDO_q12x2x1x1_2NGO,Majority provider of psycho-social supports for dementia carers (NGO)
205,GDO_q12x2x1x1_2PRV,Majority provider of psycho-social supports for dementia carers (Private sector)
206,GDO_q12x2x1x1_2PUB,Majority provider of psycho-social supports for dementia carers (Public sector)
207,GDO_q12x2x1x1_3,"Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]"
208,GDO_q12x2x1x1_3NGO,Majority provider of respite care for dementia carers (NGO)
209,GDO_q12x2x1x1_3PRV,Majority provider of respite care for dementia carers (Private sector)
210,GDO_q12x2x1x1_3PUB,Majority provider of respite care for dementia carers (Public sector)
211,GDO_q12x2x1x1_4,"Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]"
212,GDO_q12x2x1x1_4NGO,Majority provider of information on legal rights for dementia carers (NGO)
213,GDO_q12x2x1x1_4PRV,Majority provider of information on legal rights for dementia carers (Private sector)
214,GDO_q12x2x1x1_4PUB,Majority provider of information  on legal rights for dementia carers (Public sector)
215,GDO_q12x2x1x1_5,"Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]"
216,GDO_q12x2x1x1_5NGO,Majority provider of information on financial benefits/social protection for dementia carers (NGO)
217,GDO_q12x2x1x1_5PRV,Majority provider of information on financial benefits/social protection for dementia carers (Private sector)
218,GDO_q12x2x1x1_5PUB,Majority provider of information  on financial benefits/social protection for dementia carers (Public sector)
219,GDO_q12x2x1x3,Estimated number of dementia carers receiving training and education
220,GDO_q12x2x2x3,Estimated number of dementia carers receiving psycho-social supports
221,GDO_q12x2x3x3,Estimated number of dementia carers receiving respite care
222,GDO_q12x2x4x3,Estimated number of dementia carers receiving information on legal rights
223,GDO_q12x2x5x3,Estimated number of dementia carers receiving financial benefits/social protection
224,GDO_q13x1,Existence of at least one functioning dementia awareness campaign
225,GDO_q13x1x1,Implementation level [national/subnational] of dementia awareness campaign
226,GDO_q13x3,Existence of at least one functioning risk reduction campaign
227,GDO_q13x3x1,Implementation level [national/subnational] of dementia risk reduction campaign
228,GDO_q14x1,Availability of dementia-friendly initiatives that improve accessibility
229,GDO_q14x2_1,Existence of dementia-friendly initiative to improve accessibility of public spaces
230,GDO_q14x2_2,Existence of dementia-friendly initiative to improve accessibility of public transportation
231,GDO_q14x2_3,Existence of dementia-friendly initiative for assistance with home modification
232,GDO_q14x2_4,Existence of dementia-friendly initiative with assistive technology for loss of capacity
233,GDO_q14x2_5,Existence of dementia-friendly initiative supporting community places for older people
234,GDO_q14x2_6,Existence of dementia-friendly initiative supporting social opportunities
235,GDO_q15x1,Inclusion of dementia training and education for non-health workers
236,GDO_q15x2_1,Existence of dementia training for volunteers
237,GDO_q15x2_2,Existence of dementia training for police and fire services
238,GDO_q15x2_3,Existence of dementia training for first responders
239,GDO_q15x2_4,Existence of dementia training for legal professionals
240,GDO_q15x2_5,Existence of dementia training for community workers
241,GDO_q15x2_6,Existence of dementia training for school children
242,GDO_q15x2_7,Existence of dementia training for financial service staff
243,GDO_q15x2_8,Existence of dementia training for retail and hospitality staff
244,GDO_q16x1,Routine monitoring of people with dementia
245,GDO_q16x1x1_1,Data sources used to routinely monitor people with dementia (Clinical records)
246,GDO_q16x1x1_2,Data sources used to routinely monitor people with dementia (Household surveys)
247,GDO_q16x1x1_3,Data sources used to routinely monitor people with dementia (Administrative data)
248,GDO_q16x1x1_4,Data sources used to routinely monitor people with dementia (Facility survey or records)
249,GDO_q16x1x1_other,Data sources used to routinely monitor people with dementia (Other)
250,GDO_q16x1x2_1,Electronic availability of data sources used to routinely monitor people with dementia
251,GDO_q16x1x2_2,Data used to routinely monitor people with dementia can be disaggregated
252,GDO_q16x2_1,Availability of routine hospital admissions records for people with dementia for monitoring purposes
253,GDO_q16x2_2,Availability of routine outpatient visit records for people with dementia for monitoring purposes
254,GDO_q16x2_3,Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes
255,GDO_q16x2_4,Availability of routine pharmaceutical records for people with dementia for monitoring purposes
256,GDO_q16x2_5,Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes
257,GDO_q16x3,Availability and status of dementia reporting in the past two years
258,GDO_q17x1,Existence of a current dementia research plan/programme
259,GDO_q17x1x1,Implementation level [national/subnational] of dementia research plan/programme
260,GDO_q17x2,Dementia integrated into other national research plan/programme
261,GDO_q17x2x1_1,Identification of other research plans in which dementia is integrated (Mental health)
262,GDO_q17x2x1_2,Identification of other research plans in which dementia is integrated (Ageing)
263,GDO_q17x2x1_3,Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease)
264,GDO_q17x2x1_4,Identification of other research plans in which dementia is integrated (NCD)
265,GDO_q17x2x2,Implementation level [national/subnational] of research plan in which dementia is integrated
266,GDO_q18x2,Availability of funding for dementia-specific research plan/programme
267,GDO_q18x2x1_1,"Total expenditure on dementia research (local currency, self-report)"
268,GDO_q18x2x3_1,"Total expenditure on dementia basic research (local currency, self-report)"
269,GDO_q18x2x3_2,"Total expenditure on dementia clinical/translational research (local currency, self-report)"
270,GDO_q18x2x3_3,"Total expenditure on dementia implementation research (local currency, self-report)"
271,GDO_q19x2,Number of people with dementia involved in research routinely monitored
272,GDO_q19x3,Availability of investigational pharmaceutical trials for dementia
273,GDO_q19x3x1_1,Number of investigational pharmaceutical trials for dementia
274,GDO_q1x1,Inclusion of dementia in ministry portfolio
275,GDO_q1x1x1,"Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease]"
276,GDO_q1x2,Existence of dementia representative in ministry
277,GDO_q20,Total number of published dementia research output
278,GDO_q2x1,Existence of dementia national plan
279,GDO_q2x1x2,Availability of funding for dementia national plan
280,GDO_q2x1x3,Targets for monitoring implementation of dementia national plan
281,GDO_q2x2,Dementia integrated into other national plan
282,GDO_Q2x2x1_AGE,Identification of other plans in which dementia is integrated (Ageing)
283,GDO_Q2x2x1_DISAB,Identification of other plans in which dementia is integrated (Disability)
284,GDO_Q2x2x1_MENTAL,Identification of other plans in which dementia is integrated (Mental health)
285,GDO_Q2x2x1_NCD,Identification of other plans in which dementia is integrated (NCD)
286,GDO_q2x2x1_other,Identification of other plans in which dementia is integrated (Other)
287,GDO_q2x3,Existence of dementia sub-national plan(s)
288,GDO_q2x3x1_1,Percentage of sub-national regions covered by dementia plan
289,GDO_q2x4_1,Inclusion of human rights as a guiding principle of the dementia plan
290,GDO_q2x4_2,Inclusion of equity as a guiding principle of the dementia plan
291,GDO_q2x4_3,Inclusion of empowerment as a guiding principle of the dementia plan
292,GDO_q2x4_4,Inclusion of multisectoral collaboration as a guiding principles of the dementia plan
293,GDO_q2x4_5,Inclusion of universal health coverage as a guiding principle of the dementia plan
294,GDO_q2x5_1,Inclusion of dementia-friendly communities as a specific action of the dementia plan
295,GDO_q2x5_2,Inclusion of dementia risk reduction as a specific action of the dementia plan
296,GDO_q2x5_3,"Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan"
297,GDO_q2x5_4,Inclusion of dementia workforce training as a specific action of the dementia plan
298,GDO_q2x5_5,Inclusion of support for dementia carers and families as a specific action of the dementia plan
299,GDO_q2x5_6,Inclusion of improved information system as a specific action of the dementia plan
300,GDO_q2x5_7,Inclusion of research and innovation as a specific action of the dementia plan
301,GDO_q35,Estimated population-based prevalence of depression
302,GDO_q3x1,Existence of dementia legislation
303,GDO_q3x1x1_1,Implementation level [national/subnational] of dementia legislation
304,GDO_q3x2,Existence of other laws that apply to the rights of people with dementia
305,GDO_q3x3a_1,Existence of legislation for supported decision making for people with dementia
306,GDO_q3x3a_2,Existence of legislation to file appeals protecting the rights of people with dementia
307,GDO_q3x3a_3,Existence of legislation to promote community-based services for people with dementia
308,GDO_q3x3a_4,Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside
309,GDO_q3x3b_1,Existence of legislation to end coercieve practices for people with dementia
310,GDO_q3x4_1,Existence of legislation for advanced care directives for people with dementia
311,GDO_q3x4_2,Existence of legislation to end discrimination against people with dementia
312,GDO_q3x4_3,Existence of legislation to end discrimination against carers of people with dementia
313,GDO_q4x1,Existence of dementia standards/ guidelines/ protocols
314,GDO_q4x1x1_SQ001,Implementation level of dementia standards/ guidelines/ protocols (National)
315,GDO_q4x1x1_SQ002,Implementation level of dementia standards/ guidelines/ protocols (Sub-national)
316,GDO_q4x1x2,Existence of approved government dementia standards/ guidelines/ protocols
317,GDO_q4x2_1,Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia
318,GDO_q4x2_2,Existence of standards/ guidelines/ protocols for diagnosis of dementia
319,GDO_q4x2_3,Existence of standards/ guidelines/ protocols for management of dementia
320,GDO_q4x2_4,Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia
321,GDO_q4x2_5,Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia
322,GDO_q4x3x4_1,"Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia"
323,GDO_q4x3x4_2,Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia
324,GDO_q4x3x4_3,Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia
325,GDO_q4x3x4_4,Existence of standards/ guidelines/ protocols of care in hospital for people with dementia
326,GDO_q5x1,Availability of mechanisms to coordinate dementia care across sectors
327,GDO_q5x1x1_1,Identification of different sectors in dementia care coordination  (Health)
328,GDO_q5x1x1_2,Identification of different sectors in dementia care coordination (Social)
329,GDO_q5x1x1_3,Identification of different sectors in dementia care coordination (Education)
330,GDO_q5x1x1_4,Identification of different sectors in dementia care coordination (Employment)
331,GDO_q5x1x1_5,Identification of different sectors in dementia care coordination (Justice)
332,GDO_q5x1x1_6,Identification of different sectors in dementia care coordination (Housing)
333,GDO_q5x1x1_7,Identification of different sectors in dementia care coordination (Civil society)
334,GDO_q5x1x1_8,Identification of different sectors in dementia care coordination (Private sector)
335,GDO_q5x1x1_other,Identification of different sectors in dementia care coordination (Other)
336,GDO_q5x1x2,Implementation level [national/subnational] of dementia care coordination
337,GDO_q5x1x3,Presence of formal agreement/joint plan for dementia care coordination
338,GDO_q5x2,Availability of dementia care coordination standards/ guidelines/ protocols
339,GDO_q6x1_2,"Number of neurologists (per 100,000)"
340,GDO_q6x1_3,"Number of geriatricians or psychogeriatricians (per 100,000)"
341,GDO_q6x2_1,Inclusion of basic dementia competencies in training of physicians
342,GDO_q6x2_2,Inclusion of basic dementia competencies in training of specialists
343,GDO_q6x2_3,Inclusion of basic dementia competencies in training of nurses
344,GDO_q6x2_4,Inclusion of basic dementia competencies in training of pharmaceutical personnel
345,GDO_q6x2_5,Inclusion of basic dementia competencies in training of social workers
346,GDO_q6x2_6,Inclusion of basic dementia competencies in training of personal support workers
347,GDO_q7x1_AVAIL,Availability of dementia diagnostic rate
348,GDO_q8x1,Existence of community-based health or social care services for dementia
349,GDO_q8x2_1,Availability of diagnostic services in community for dementia
350,GDO_q8x2_2,Availability of behaviour and psychological management in community for dementia
351,GDO_q8x2_3,Availability of psychosocial and rehabilitation services in community for dementia
352,GDO_q8x2_4,Availability of activities of daily living support services in community for dementia
353,GDO_q8x2_5,Availability of palliative and end-of-life care services in community for dementia
354,GDO_q8x2_6,Availability of social and financial protection for dementia
355,GDO_q8x3_1,"Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
356,GDO_q8x3_2,"Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
357,GDO_q8x3_3,"Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
358,GDO_q8x3_4,"Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
359,GDO_q8x3_5,"Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
360,GDO_q8x3_6,"Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas]"
361,GDO_q8x4_1,"Majority provider of diagnostic services in community for dementia [public, private]"
362,GDO_q8x4_2,"Majority provider of behaviour and psychological management in community for dementia [public, private]"
363,GDO_q8x4_3,"Majority provider of psychosocial and rehabilitation services in community for dementia [public, private]"
364,GDO_q8x4_4,"Majority provider of activities of daily living support services in community for dementia [public, private]"
365,GDO_q8x4_5,"Majority provider of palliative and end-of-life care services in community for dementia [public, private]"
366,GDO_q8x4_6,"Majority provider of social and financial protection for dementia [public, private]"
367,GDO_q8x5_2,Estimated number of people receiving behaviour and psychological management services in community for dementia
368,GDO_q8x5_3,Estimated number of people receiving psychosocial and rehabilitation services in community for dementia
369,GDO_q8x5_4,Estimated number of people receiving activities of daily living support services in community for dementia
370,GDO_q8x5_5,Estimated number of people receiving palliative and end-of-life care services in community for dementia
371,GDO_q8x5_6,Estimated number of people with dementia receiving social and financial protection for dementia
372,GDO_q9_1,Dementia care facilities [hospitals]
373,GDO_q9_2,Care facilities [long-term care]
374,GDO_q9_3,Care facilities [hospice centres]
375,GDO_q9_4,Adult day centres
376,GDO_q9_5,Outpatient health centres
377,GDO_q9_6,Outpatient social centres
378,GDO_q9x1_3,"Dementia-specific hospital beds (per 10,000 population)"
379,GDO_q9x1_4,"Geriatric-specific hospital beds (per 10,000 population)"
380,GDO_q9x1_5,"Total dementia hospital admissions (per 100,000)"
381,GDO_q9x1_7,Estimated percentage of hospitals following national dementia standards
382,GDO_q9x2_1,"Density of residential long-term care facilities (per 100,000 population)"
383,GDO_q9x2_2,Residential long-term care beds (per 10 000 population)
384,GDO_q9x2_3,"Dementia-specific residential long-term care beds (per 10,000 population)"
385,GDO_q9x2_4,Estimated number of people with dementia living in residential long-term care
386,GDO_q9x2_5,Estimated percentage of residential long-term care facilities following national dementia standards
387,GDO_q9x3_1,"Density of hospice centres (per 100,000 population)"
388,GDO_q9x3_2,Hospice centre beds (per 10 000 population)
389,GDO_q9x3_3,"Dementia-specific hospice care beds (per 10,000 population)"
390,GDO_q9x4_1,"Density of adult day centres (per 100,000 population)"
391,GDO_q9x4_2,"Adult day centre places (per 10,000 population)"
392,GDO_q9x4_3,"Dementia-specific adult day centre places (per 10,000 population)"
393,GDO_q9x5_1,"Density of outpatient health centres (per 100,000 population)"
394,GDO_q9x5_2,Estimated number of people with dementia receiving services at outpatient health centre
395,GDO_q9x6_1,"Density of outpatient social centres (per 100,000 population)"
396,GDO_q9x6_2,Estimated number of people with dementia receiving services at outpatient social centre
397,GHE_DALYNUM,Disability-adjusted life years (DALYs)
398,GHE_DALYRATE,Disability-adjusted life years (DALYs) (per 100 000 population)
399,GHE_YLDNUM,Years of healthy life lost due to disability (YLDs)
400,GHE_YLDRATE,Years of healthy life lost due to disability (YLDs) (per 100 000 population)
401,GHE_YLLNUM,Years of life lost from mortality (YLLs)
402,GHE_YLLRATE,Years of life lost from mortality (YLLs) (per 100 000 population)
403,GHED_CHE_pc_PPP_SHA2011,Current health expenditure (CHE) per capita in PPP int$
404,GHED_CHE_pc_US_SHA2011,Current health expenditure (CHE) per capita in US$
405,GHED_CHEGDP_SHA2011,Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%)
406,GHED_EXT_pc_PPP_SHA2011,External health expenditure (EXT) per capita in PPP int$
407,GHED_EXT_pc_US_SHA2011,External health expenditure (EXT) per capita in US$
408,GHED_EXTCHE_SHA2011,External health expenditure (EXT) as percentage of current health expenditure (CHE) (%)
409,GHED_GGHE-D_pc_PPP_SHA2011,Domestic general government health expenditure (GGHE-D) per capita in PPP int$
410,GHED_GGHE-D_pc_US_SHA2011,Domestic general government health expenditure (GGHE-D) per capita in US$
411,GHED_GGHE-DCHE_SHA2011,Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%)
412,GHED_GGHE-DGDP_SHA2011,Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%)
413,GHED_GGHE-DGGE_SHA2011,Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%)
414,GHED_OOP_pc_PPP_SHA2011,Out-of-pocket expenditure (OOP) per capita in PPP int$
415,GHED_OOP_pc_US_SHA2011,Out-of-pocket expenditure (OOP) per capita in US$
416,GHED_OOPSCHE_SHA2011,Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%)
417,GHED_PVT-D_pc_PPP_SHA2011,Domestic private health expenditure (PVT-D) per capita in PPP int$
418,GHED_PVT-D_pc_US_SHA2011,Domestic private health expenditure (PVT-D) per capita in US$
419,GHED_PVT-DCHE_SHA2011,Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%)
420,GOE_Q001,National universal health coverage strategy
421,GOE_Q002,strategy refers to the use of ICT to support UHC
422,GOE_Q003,National eHealth strategy
423,GOE_Q004,National eHealth strategy refers to objectives of UHC
424,GOE_Q006,National  health information system (HIS) policy or strategy
425,GOE_Q007,Public funding for eHealth
426,GOE_Q008,Private funding for eHealth
427,GOE_Q009,Donor/ non-public development funding for eHealth
428,GOE_Q010,Public-private partnerships for eHealth
429,GOE_Q011,Strategy implementation funding available for eHealth
430,GOE_Q012,Proportion of public funding
431,GOE_Q013,Proportion of private funding
432,GOE_Q014,Proportion of donor/non public development funding
433,GOE_Q015,Proportion ofpublic private partnerships funding
434,GOE_Q017,Government-supported health internet sites provide information in multiple languages
435,GOE_Q018,Tertiary institutions provide students of health sciences with training on eHealth
436,GOE_Q022,Institutions offer in-service training to health professionals on ICT for health
437,GOE_Q028,mHealth programmes are sponsored by government
438,GOE_Q030_1,Regulating mobile devices and software
439,GOE_Q030_2,Promoting standards and interoperability
440,GOE_Q030_3,Providing guidance on privacy and security
441,GOE_Q030_4,Providing oversight and enforcement of data ownership
442,GOE_Q030_5,Promoting the development and adoption of mHealth
443,GOE_Q031,"Regulatory oversight of mobile apps for quality, safety and reliability"
444,GOE_Q032,Providing incentives and guidance for innovation research and evaluation of health
445,GOE_Q047,Government-sponsored mHealth programmes are being evaluated
446,GOE_Q057,Capacity
447,GOE_Q058,Infrastructure
448,GOE_Q059,Funding
449,GOE_Q060,Effectiveness
450,GOE_Q061,Cost-effectiveness
451,GOE_Q062,Demand
452,GOE_Q063,Legal
453,GOE_Q064,Policy
454,GOE_Q065,Priorities
455,GOE_Q069,Country has telehealth policy or strategy
456,GOE_Q070,Strategy includes objectives as to how telehealth contributes to UHC
457,GOE_Q081,Evaluation of any government-sponsored telehealth programmes
458,GOE_Q103,eLearning is used in pre-service education to teach health sciences students
459,GOE_Q104_1,Reducing cost of delivering content
460,GOE_Q104_2,Improving access to content and experts
461,GOE_Q104_3,Enabling access to education where learning facilities are limited
462,GOE_Q109,Pre-service eLearning programmes have been evaluated
463,GOE_Q118,eLearning used for in-service training of health professionals
464,GOE_Q119_1,Reducing cost of delivering content
465,GOE_Q119_2,Improving access to content and experts
466,GOE_Q119_3,Enabling access to education where learning facilities are limited
467,GOE_Q120,eLearning courses accredited by continuing medical education or professional licensing bodies
468,GOE_Q122,eLearning programmes for in-service training of health professionals have been evaluated
469,GOE_Q131,Lack of capacity
470,GOE_Q132,Lack of infrastructure
471,GOE_Q133,Lack of funding
472,GOE_Q134,Not possible to gain a health sciences degree entirely through eLearning
473,GOE_Q135,Lack of evidence that eLearning is effective
474,GOE_Q136,Lack of evidence over cost-effectiveness
475,GOE_Q137,Lack of demand for eLearning programmes
476,GOE_Q138,Lack of suitable courses available
477,GOE_Q139,Insitutional educational policy does not include eLearning as an approach to teaching health sciences
478,GOE_Q140,Competing educational priorities
479,GOE_Q144,Country has national EHR
480,GOE_Q146,Country has specific legislation governing the use of national EHR system
481,GOE_Q153,Lack of capacity
482,GOE_Q154,Lack of infrastructure
483,GOE_Q155,Lack of funding
484,GOE_Q156,lack of evidence showing effectiveness of EHR
485,GOE_Q157,Lack of evidence showing cost-effectiveness or EHR
486,GOE_Q158,Lack of demand by health professionals and patients
487,GOE_Q159,Lack of legislation or regulations covering use of EHR
488,GOE_Q160,National strategy does not promote the adoption of EHR
489,GOE_Q161,Lack of national or international standards for interoperability of EHR
490,GOE_Q162,Competing health system priorities
491,GOE_Q168,"To define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth"
492,GOE_Q169,"To address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria"
493,GOE_Q170,To protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format
494,GOE_Q171,To protect the privacy of individuals' health-related  data held in electronic format as an EHR
495,GOE_Q172,Which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR
496,GOE_Q173,Which governs the sharing of digital data between health professionals  in health services in other countries through the use of an EHR
497,GOE_Q174,Which allows for the sharing of personal and health data between research entities
498,GOE_Q175,Which allows individuals electronic access to their own health-related data when held in an EHR
499,GOE_Q176,Which allows individuals to demand that their own data be corrected  when held in an EHR if it is known to be inaccurate
500,GOE_Q177,Which allows individuals to demand the deletion of health-related data from their EHR
501,GOE_Q178,Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice
502,GOE_Q181,Country has national policy or strategy on the use of social media by government organizations
503,GOE_Q182,Policy or strategy makes specific reference tothe use of social media in the health domain
504,GOE_Q196,Country has  national policy or strategy regulating the use of big data in the health sector
505,GOE_Q197,Country has national policy or strategy regulating the use of big data by private companies
506,GOE_Q198,Effective standards and best practices for data capture not fully established
507,GOE_Q199,Insufficient incentives for data sharing
508,GOE_Q200,Capacity building required for new skills
509,GOE_Q201,Privacy and security laws need to be in place
510,GOE_Q202,Research into new analytical methods needs occur to meet the challenges of working with big data
511,GOE_Q203,Lack of integration between various health services
512,HIV_0000000001,Estimated number of people (all ages) living with HIV
513,HIV_0000000006,Number of people dying from HIV-related causes
514,HIV_0000000007,"Testing and counselling facilities, reported number"
515,HIV_0000000008,"Testing and counselling facilities, estimated number per 100 000 adult population"
516,HIV_0000000009,Reported number of people receiving antiretroviral therapy
517,HIV_0000000011,Reported number of children receiving antiretroviral therapy
518,HIV_0000000012,"Reported number of children receiving antiretroviral therapy, month and year of report"
519,HIV_0000000015,Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
520,HIV_0000000020,Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
521,HIV_0000000021,Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission
522,HIV_0000000022,Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines
523,HIV_0000000023,Estimated number of children needing antiretroviral therapy based on WHO methods
524,HIV_0000000024,Estimated antiretroviral therapy coverage among children
525,HIV_0000000025,"Testing and counselling facilities, reporting period"
526,HIV_0000000026,Number of new HIV infections
527,HIV_ARTCOVERAGE,Estimated antiretroviral therapy coverage among people living with HIV (%)
528,HRH_40,Biomedical engineers density (per 10 000 population)
529,HRH_41,Number of licensed qualified surgeons actively working
530,HRH_42,Number of licensed qualified obstetricians actively working
531,HRH_43,Number of licensed qualified anaesthesiologists actively working
532,HRH_44,Number of biomedical engineers
533,HRH_45,Biomedical technicians density (per 10 000 population)
534,HRH_46,Number of biomedical technicians
535,HSS_UHCLEGISLATION,Countries that have passed legislation on Universal Health Coverage (UHC)
536,HWF_0001,"Medical doctors (per 10,000)"
537,HWF_0002,Medical doctors (number)
538,HWF_0003,Generalist medical practitioners (number)
539,HWF_0004,Specialist medical practitioners (number)
540,HWF_0005,Medical doctors not further defined (number)
541,HWF_0006,"Nursing and midwifery personnel (per 10,000)"
542,HWF_0007,Nursing and midwifery personnel  (number)
543,HWF_0008,Nursing personnel (number)
544,HWF_0009,Midwifery personnel (number)
545,HWF_0010,"Dentists (per 10,000)"
546,HWF_0011,Dentists (number)
547,HWF_0012,Dental Assistants and Therapists (number)
548,HWF_0013,Dental Prosthetic Technicians (number)
549,HWF_0014,"Pharmacists  (per 10,000)"
550,HWF_0015,Pharmacists  (number)
551,HWF_0016,Pharmaceutical Technicians and Assistants  (number)
552,HWF_0017,Environmental and Occupational Health and Hygiene Professionals  (number)
553,HWF_0018,Environmental and Occupational Health Inspectors and Associates  (number)
554,HWF_0019,Medical and Pathology Laboratory scientists  (number)
555,HWF_0020,Medical and Pathology Laboratory Technicians  (number)
556,HWF_0021,Physiotherapists (number)
557,HWF_0022,Physiotherapy Technicians and Assistants  (number)
558,HWF_0023,Traditional and Complementary Medicine Professionals  (number)
559,HWF_0024,Community Health Workers (number)
560,HWWS_1,Handwashing with soap after using the toilet (%)
561,HWWS_2,Handwashing with soap after cleaning child's stool (%)
562,IHR01,Legislation
563,IHR02,Coordination
564,IHR03,Surveillance
565,IHR04,Response
566,IHR05,Preparedness
567,IHR06,Risk communication
568,IHR07,Human resources
569,IHR08,Laboratory
570,IHR09,Points of entry
571,IHR10,Zoonosis
572,IHR11,Food safety
573,IHR12,Chemical
574,IHR13,Radionuclear
575,imr,Infant mortality rate (deaths per 1000 live births)
576,IR_CARBAMATE_EXTENT,Percentage of sites for which carbamate resistance was reported
577,IR_CARBAMATE_PRESENCE,Carbamate resistance reported for at least one site
578,IR_INSECTICIDERESISTANCE_PREV,Number of insecticide classes to which resistance was reported
579,IR_ORGANOCHLORINE_EXTENT,Percentage of sites for which organochlorine resistance was reported
580,IR_ORGANOCHLORINE_PRESENCE,Organochlorine resistance reported for at least one site
581,IR_ORGANOPHOSPHATE_EXTENT,Percentage of sites for which organophosphate resistance was reported
582,IR_ORGANOPHOSPHATE_PRESENCE,Organophosphate resistance reported for at least one site
583,IR_PYRETHROID_EXTENT,Percentage of sites for which pyrethroid resistance was reported
584,IR_PYRETHROID_PRESENCE,Pyrethroid resistance reported for at least one site
585,itnch,Children aged < 5 years sleeping under insecticide-treated nets (%)
586,itnwm,Pregnant women sleeping under insecticide-treated nets (%)
587,ITU_ICT_1,Percentage of individuals using the Internet
588,ITU_ICT_2,Mobile-cellular telephone subscriptions per 100 inhabitants
589,ITU_IDI,ICT Development Index (IDI)
590,ITU_IDI_RANK,ICT Development Index (IDI) rank
591,LEAD_1,Percentage of the children under 15 years with blood lead levels above 5ug/dl
592,LEAD_10,Lead attributable DALYs per 100'000 children under 5 years
593,LEAD_2,Percentage of the children under 15 years with blood lead levels above 10ug/dl
594,LEAD_3,Percentage of the adults (15+ years) with blood lead levels above 5ug/dl
595,LEAD_4,Percentage of the adults (15+ years) with blood lead levels above 10ug/dl
596,LEAD_5,Lead attributable deaths
597,LEAD_6,Lead attributable DALYs ('000)
598,LEAD_7,Lead attributable deaths per 100'000 capita
599,LEAD_8,Lead attributable DALYs per 100'000 capita
600,LEAD_9,Lead attributable DALYs ('000) in children under 5 years
601,LEADCONTROL,Legally-binding controls on lead paint
602,LIFE_0000000029,nMx - age-specific death rate between ages x and x+n
603,LIFE_0000000030,nqx - probability of dying between ages x and x+n
604,LIFE_0000000031,lx - number of people left alive at age x
605,LIFE_0000000032,ndx - number of people dying between ages x and x+n
606,LIFE_0000000033,nLx - person-years lived between ages x and x+n
607,LIFE_0000000034,Tx - person-years lived above age x
608,LIFE_0000000035,ex - expectation of life at age x
609,M_def_1_prev_adult,Adult indicator 1 rate
610,M_def_1_prev_youth,Youth indicator 1 rate
611,M_def_1_text_adult,Adult indicator 1 definition
612,M_def_1_text_youth,Youth indicator 1 definition
613,M_def_2_prev_adult,Adult indicator 2 rate
614,M_def_2_prev_youth,Youth indicator 2 rate
615,M_def_2_text_adult,Adult indicator 2 definition
616,M_def_2_text_youth,Youth indicator 2 definition
617,M_Est_cig_curr,Estimate of current cigarette smoking prevalence (%)
618,M_Est_tob_curr,Estimate of current tobacco use prevalence (%)
619,M_Group,Monitoring tobacco use and prevention policies
620,M_smkless_age_range_adult,Adult survey age range - smokeless
621,M_smkless_age_range_youth,Youth survey age range - smokeless
622,M_smkless_def_text_adult,Adult smokeless tobacco use indicator definition
623,M_smkless_def_text_youth,Youth smokeless tobacco use indicator definition
624,M_smkless_prev_adult,Adult smokeless tobacco use indicator rate
625,M_smkless_prev_youth,Youth smokeless tobacco use indicator rate
626,M_smkless_survey_title_adult,Name of survey of adults - smokeless
627,M_smkless_survey_title_youth,Name of survey of youth - smokeless
628,M_smkless_svy_national_adult,Representativeness of survey of adults - smokeless
629,M_smkless_svy_national_youth,Representativeness of survey of youth - smokeless
630,M_survey_title_adult,Name of survey of adults
631,M_survey_title_youth,Name of survey of youth
632,M_svy_age_adult,Adult survey age range
633,M_svy_age_youth,Youth survey age range
634,M_svy_national_adult,Representativeness of survey of adults
635,M_svy_national_youth,Representativeness of youth survey
636,MCV2,Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)
637,MDG_0000000001,Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
638,MDG_0000000003,Adolescent birth rate (per 1000 women aged 15-19 years)
639,MDG_0000000007,Under-five mortality rate (probability of dying by age 5 per 1000 live births)
640,MDG_0000000010,Median availability of selected generic medicines (%) - Public
641,MDG_0000000011,Median consumer price ratio of selected generic medicines - Public
642,MDG_0000000015,Prevalence of condom use by adults during higher-risk sex (15-49) (%)
643,MDG_0000000017,Deaths due to tuberculosis among HIV-negative people (per 100 000 population)
644,MDG_0000000020,Incidence of tuberculosis (per 100 000 population per year)
645,MDG_0000000021,Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%)
646,MDG_0000000025,Births attended by skilled health personnel (%)
647,MDG_0000000026,Maternal mortality ratio (per 100 000 live births)
648,MDG_0000000029,Prevalence of HIV among adults aged 15 to 49 (%)
649,MDG_0000000030,Smear-positive tuberculosis case-detection rate (%)
650,MDG_0000000031,Smear-positive tuberculosis treatment-success rate (%)
651,MDG_0000000032,Maternal mortality ratio (per 100 000 live births) - Country reported estimates
652,MDG_0000000033,Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)
653,MDG_0000000034,"Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines"
654,MENING_1,Number of suspected meningitis deaths reported
655,MENING_2,Number of suspected meningitis cases reported
656,MENING_3,Number of meningitis epidemic districts
657,MH_1,Mental health policy
658,MH_10,"Mental health outpatient facilities (per 100,000)"
659,MH_11,"Mental health day treatment facilities (per 100,000)"
660,MH_12,Age-standardized suicide rates (per 100 000 population)
661,MH_13,"Beds for mental health in general hospitals (per 100,000)"
662,MH_14,"Community residential facilities (per 100,000)"
663,MH_15,"Beds in community residential facilities (per 100,000)"
664,MH_16,"Beds in mental hospitals (per 100,000)"
665,MH_17,"Mental hospitals (per 100,000)"
666,MH_18,"Mental health units in general hospitals (per 100,000)"
667,MH_19,"Mental hospital admissions (per 100,000)"
668,MH_2,Mental health plan
669,MH_20,"Outpatient visits (per 100,000)"
670,MH_24,"Mental health units in general hospitals admissions (per 100,000)"
671,MH_25,Stand-alone policy or plan for mental health
672,MH_3,Stand-alone mental health legislation
673,MH_4,Government expenditures on mental health as a percentage of total government expenditures on health (%)
674,MH_5,Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)
675,MH_6,"Psychiatrists working in mental health sector (per 100,000)"
676,MH_7,"Nurses working in mental health sector (per 100,000)"
677,MH_8,"Social workers working in mental health sector (per 100,000)"
678,MH_9,"Psychologists working in mental health sector (per 100,000)"
679,MORT_100,Number of deaths
680,MORT_200,Deaths per 1 000 live births
681,MORT_300,Distribution of causes of death among children aged < 5 years (%)
682,MORT_600,Projection of number of deaths
683,MORT_700,Projection of deaths per 100 000 population
684,MORT_MATERNALNUM,Number of maternal deaths
685,MORTADO,Adolescent mortality rate (per 100 000 population)
686,NCD_BMI_18A,"Prevalence of underweight among adults, BMI < 18 (age-standardized estimate) (%)"
687,NCD_BMI_18C,"Prevalence of underweight among adults, BMI < 18 (crude estimate) (%)"
688,NCD_BMI_25A,"Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)"
689,NCD_BMI_25C,"Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)"
690,NCD_BMI_30A,"Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)"
691,NCD_BMI_30C,"Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)"
692,NCD_BMI_MEAN,Mean BMI (kg/m²) (age-standardized estimate)
693,NCD_BMI_MEANC,Mean BMI (kg/m&#xb2;) (crude estimate)
694,NCD_BMI_MINUS2C,"Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)"
695,NCD_BMI_PLUS1C,"Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)"
696,NCD_BMI_PLUS2C,"Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)"
697,NCD_CCS_ACE,General availability of ACE inhibitors in the public health sector
698,NCD_CCS_AlcPlan,Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol
699,NCD_CCS_Aspirin,General availability of aspirin (100 mg) in the public health sector
700,NCD_CCS_betablockers,General availability of beta blockers in the public health sector
701,NCD_CCS_BowelCancer,General availability of colon cancer screening at the primary health care level
702,NCD_CCS_BreastCancer,General availability of breast cancer screening (by palpation or mammogram) at the primary health care level
703,NCD_CCS_breastcancerscreening,Existence of national screening program for breast cancer
704,NCD_CCS_Bronchodilators,General availability of bronchodilators in the public health sector
705,NCD_CCS_CancerPlan,Existence of operational policy/strategy/action plan for cancer
706,NCD_CCS_CancerRegNational,Existence of population-based cancer registry
707,NCD_CCS_CCBlkrs,General availability of CC blockers in the public health sector
708,NCD_CCS_CervCy,General availability of cervical cytology at the primary health care level
709,NCD_CCS_cervicalcancermethod,Most widely used screening method in national cervical cancer screening program
710,NCD_CCS_cervicalcancerpgmcvg,Coverage of national cervical cancer screening program (%)
711,NCD_CCS_cervicalcancerpgmtype,Type of national cervical cancer screening program
712,NCD_CCS_cervicalcancerscreening,Existence of national screening program for cervical cancer
713,NCD_CCS_chemo,General availability of chemotherapy in the public health system
714,NCD_CCS_CholMsmt,General availability of total cholesterol measurement at the primary health care level
715,NCD_CCS_coronary,General availability of coronary bypass or stenting in the public health system
716,NCD_CCS_CRDPlan,Existence of operational policy/strategy/action plan for chronic respiratory diseases
717,NCD_CCS_CVDPlan,Existence of operational policy/strategy/action plan for cardiovascular diseases
718,NCD_CCS_DiabetesReg,Existence of a diabetes registry
719,NCD_CCS_DiabetesTest,"General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level"
720,NCD_CCS_DiabPlan,Existence of operational policy/strategy/action plan for diabetes
721,NCD_CCS_diabtest,"General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level"
722,NCD_CCS_dialysis,General availability of dialysis in the public health system
723,NCD_CCS_dietpaaware,Implementation of diet and/or physical activity public awareness program
724,NCD_CCS_DietPlan,Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs
725,NCD_CCS_HbA1c,General availability of diabetes testing (by HbA1c) at the primary health care level
726,NCD_CCS_hpv,Existence of national HPV vaccination programme
727,NCD_CCS_Insulin,General availability of insulin in the public health sector
728,NCD_CCS_integNCDplan,"Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors"
729,NCD_CCS_Metformin,General availability of metformin in the public health sector
730,NCD_CCS_Mkting,Existence of any policies on marketing of foods to children
731,NCD_CCS_MultisecComm,"Existence of a national multisectoral commission, agency or mechanism for NCDs"
732,NCD_CCS_NCDGuide,Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach
733,NCD_CCS_NCDIndicators,Existence of a set of national NCD indicators and has set time-bound national targets for these indicators
734,NCD_CCS_NCDUnit_Operational,"Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs"
735,NCD_CCS_Nicotine,General availability of nicotine replacement therapy in the public health sector
736,NCD_CCS_oralhealthplan,Existence of operational policy/strategy/action plan for oral health
737,NCD_CCS_OralMorph,General availability of oral morphine in the public health sector
738,NCD_CCS_paaware,Implementation of physical activity public awareness program
739,NCD_CCS_palliative_home,General availability of palliative care in community or home-based care in the public health system
740,NCD_CCS_palliative_prim,General availability of palliative care in primary health care in the public health system
741,NCD_CCS_PAPlan,Existence of operational policy/strategy/action plan to reduce physical inactivity
742,NCD_CCS_PeakFlow,General availability of peak flow measurement at the primary health care level
743,NCD_CCS_photocoag,General availability of retinal photocoagulation in the public health system
744,NCD_CCS_PM3_Surv,Has a STEPS survey or a comprehensive health examination survey every 5 years
745,NCD_CCS_renaltrans,General availability of renal replacement by transplantation in the public health system
746,NCD_CCS_rheum,Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities
747,NCD_CCS_rheumfollowup,Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease
748,NCD_CCS_rheumreg,Existence of a register of patients who had rheumatic fever and rheumatic heart disease
749,NCD_CCS_riskstrat,Availability of cardiovascular risk stratification in 50% or more primary health care facilities
750,NCD_CCS_SaltPol,Existence of any policies to reduce population salt consumption
751,NCD_CCS_SatFat,Existence of national policies on saturated fatty acids / trans-fats
752,NCD_CCS_Spirom,General availability of spirometry at the primary health care level
753,NCD_CCS_SSBTAX,Existence of tax on sugar-sweetened beverages
754,NCD_CCS_Statins,General availability of statins in the public health sector
755,NCD_CCS_Steroid,General availability of steroid inhalers in the public health sector
756,NCD_CCS_stroke,Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities
757,NCD_CCS_sulphonylurea,General availability of sulphonylurea(s) in the public health sector
758,NCD_CCS_SurvMonRep9NCD,Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets
759,NCD_CCS_targets,Existence of a set of time-bound national targets based on WHO guidance
760,NCD_CCS_Thiazide,General availability of thiazide diuretics in the public health sector
761,NCD_CCS_thrombolytic,General availability of thrombolytic therapy in the public health system
762,NCD_CCS_TobPlan,Existence of operational policy/strategy/action plan to decrease tobacco use
763,NCD_CCS_UrineAlbumin,General availability of urine testing for albumin
764,NCD_DTH_TOT,Total NCD Deaths (in thousands)
765,NCD_GLUC_01,Mean fasting blood glucose (mmol/l) (age-standardized estimate)
766,NCD_GLUC_02,Mean fasting blood glucose (mmol/l) (crude estimate)
767,NCD_GLUC_03,Raised fasting blood glucose (>= 7.0 mmol/L) (crude estimate)
768,NCD_GLUC_04,Raised fasting blood glucose (>=7.0 mmol/L) (age-standardized estimate)
769,NCD_PAA,Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)
770,NCD_PAC,Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%)
771,NCD_PAC_ADO,Insufficiently active (crude estimate)
772,NCD_UNDER70,Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths
773,NCDMORT3070,"Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease"
774,NHABASIS,Basis for NHA estimate
775,nmr,Neonatal mortality rate (deaths per 1000 live births)
776,NTCP_agcy,National agency for tobacco control exists
777,NTCP_budget_year,Budget year
778,NTCP_curr,Reported currency
779,NTCP_FTE,Number of full-time equivalent staff in national agency
780,NTCP_govt_exp,Annual budget for tobacco control in currency reported
781,NTCP_govt_obj,Government objectives on tobacco control exist
782,NTD_1,Number of new reported cases of Buruli ulcer
783,NTD_2,Dracunculiasis certification status of countries at the beginning of the year
784,NTD_3,Annual incidence of dracunculiasis cases
785,NTD_4,Number of new reported cases of human African trypanosomiasis (T.b. gambiense)
786,NTD_5,Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense)
787,NTD_6,Status of elimination of trachoma as a public health problem
788,NTD_7,"Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem"
789,NTD_8,Number of people who received treatment with antibiotics for trachoma
790,NTD_BEJELSTATUS,Status of bejel endemicity
791,NTD_LEISHCEND,Status of endemicity of cutaneous leishmaniasis
792,NTD_LEISHCNUM,Number of cases of cutaneous leishmaniasis reported
793,NTD_LEISHCNUM_IM,Number of imported cases of cutaneous leishmaniasis reported
794,NTD_LEISHVEND,Status of endemicity of visceral leishmaniasis
795,NTD_LEISHVNUM,Number of cases of visceral leishmaniasis reported
796,NTD_LEISHVNUM_IM,Number of imported cases of visceral leishmaniasis reported
797,NTD_LEPR11,Number of female leprosy new cases
798,NTD_LEPR2,New leprosy case detection rate per 1 000 000 population
799,NTD_LEPR3,Leprosy - Number of cases registered for treatment
800,NTD_LEPR4,Leprosy registered prevalence rate per 1 000 000 population
801,NTD_LEPR5,Number of new G2D leprosy cases
802,NTD_LEPR7,Leprosy - New leprosy cases with G2D rate per 1 000 000 population
803,NTD_LEPR8,Leprosy - Number of new leprosy cases among children (less than 15 years of age)
804,NTD_LEPR9,Number of new leprosy cases with G2D among children (less than 15 years of age)
805,NTD_ONCHEMO,Estimated number of individuals in the country requiring preventive chemotherapy for onchocerciasis
806,NTD_ONCHSTATUS,Status of endemicity of onchocerciasis
807,NTD_ONCTREAT,Reported number of individuals treated for onchocerciasis
808,NTD_PINTASTATUS,Status of pinta endemicity
809,NTD_RAB2,Reported number of human rabies deaths
810,NTD_TRA5,Number of people operated for trachomatous trichiasis
811,NTD_TSOL1,Status of endemicity of Taenia solium
812,NTD_TSOL3,Number of pigs in the country
813,NTD_TSOL4,Practice of backyard pig production
814,NTD_YAWSEND,Status of yaws endemicity
815,NTD_YAWSNUM,Number of cases of yaws reported
816,NUTOVERWEIGHTNUM,"Overweight numbers among children under 5 years of age (millions), model-based estimates"
817,NUTOVERWEIGHTPREV,"Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates"
818,NUTRITION_2005,Proportion of children aged 6-23 months who receive a minimum acceptable diet
819,NUTRITION_564,Children aged <5 years wasted for age (%)
820,NUTRITION_570,Early initiation of breastfeeding (%)
821,NUTRITION_579,Exclusive breastfeeding under 6 months (%)
822,NUTRITION_ANT_HAZ_NE2,"Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), survey-based estimates"
823,NUTRITION_ANT_WHZ_NE2,"Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), survey-based estimates"
824,NUTRITION_WA_2,"Underweight prevalence among children under 5 years of age   (% weight-for-age <-2 SD), survey-based estimates"
825,NUTRITION_WH_2,"Wasting prevalence among children under 5 years of age (% weight-for-height <-2 SD), survey-based estimates"
826,NUTRITION_WH_3,"Severe wasted prevalence among children under 5 years of age   (% weight-for-height <-3 SD), survey-based estimates"
827,NUTSEVWASTINGNUM,"Severe wasted numbers among children under 5 years of age (millions), model-based estimates"
828,NUTSEVWASTINGPREV,"Severe wasted prevalence among children under 5 years of age (%), model-based estimates"
829,NUTSTUNTINGNUM,"Stunting numbers among children under 5 years of age (millions), model-based estimates"
830,NUTSTUNTINGPREV,"Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates"
831,NUTUNDERWEIGHTNUM,"Underweight numbers among children under 5 years of age (millions), model-based estimates"
832,NUTUNDERWEIGHTPREV,"Underweight prevalence among children under 5 years of age (%), model-based estimates"
833,NUTWASTINGNUM,"Wasted numbers among children under 5 years of age (millions), model-based estimates"
834,NUTWASTINGPREV,"Wasted prevalence among children under 5 years of age (%), model-based estimates"
835,O_Avail_community,Treatment for tobacco dependence available in the community
836,O_Avail_hlth_clin,Treatment for tobacco dependence available in health clinics or other primary care facilities
837,O_Avail_hosp,Treatment for tobacco dependence available in hospitals
838,O_Avail_off_hlth_prof,Treatment for tobacco dependence available in offices of health professionals
839,O_Avail_other,Treatment for tobacco dependence available in other settings
840,O_Bup_ins,Bupropion - cost covered
841,O_Bup_sold,Bupropion - legally sold
842,O_Bup_where,Bupropion - place available
843,O_Group,Offering help to quit tobacco use
844,O_Ins_community,Treatment for tobacco dependence in the community cost covered
845,O_Ins_hlth_clin,Treatment for tobacco dependence in health clinics or other primary care facilities cost covered
846,O_Ins_hosp,Treatment for tobacco dependence in hospitals cost covered
847,O_Ins_off_hlth_prof,Treatment for tobacco dependence in offices of health professionals cost covered
848,O_Ins_other,Treatment for tobacco dependence in other settings cost covered
849,O_NRT_EML,Nicotine replacement therapy on the Essential Medicines List
850,O_NRT_ins,Nicotine replacement therapy - cost covered
851,O_NRT_sold,Nicotine replacement therapy - legally sold
852,O_NRT_where,Nicotine replacement therapy - place available
853,O_Quitline,Access to a toll-free quit line
854,O_Varen_ins,Varenicline - cost covered
855,O_Varen_sold,Varenicline - legally sold
856,O_Varen_where,Varenicline - place available
857,OCC_1,Occupational risk factors attributable deaths
858,OCC_10,Occupational carcinogens attributable DALYs ('000)
859,OCC_11,Occupational carcinogens attributable deaths per 100'000 capita
860,OCC_12,Occupational carcinogens attributable DALYs per 100'000 capita
861,OCC_13,Occupational noise attributable DALYs ('000)
862,OCC_14,Occupational noise attributable DALYs per 100'000 capita
863,OCC_15,Occupational ergonomic stressors attributable deaths
864,OCC_16,Occupational ergonomic stressors attributable DALYs ('000)
865,OCC_17,Occupational ergonomic stressors attributable deaths per 100'000 capita
866,OCC_18,Occupational ergonomic stressors attributable DALYs per 100'000 capita
867,OCC_19,Occupational injuries attributable deaths
868,OCC_2,Occupational risk factors attributable DALYs ('000)
869,OCC_20,Occupational injuries attributable DALYs ('000)
870,OCC_21,Occupational injuries attributable deaths per 100'000 capita
871,OCC_22,Occupational injuries attributable DALYs per 100'000 capita
872,OCC_3,Occupational risk factors attributable deaths per 100'000 capita
873,OCC_4,Occupational risk factors attributable DALYs per 100'000 capita
874,OCC_5,Occupational airborne particulates attributable deaths
875,OCC_6,Occupational airborne particulates attributable DALYs ('000)
876,OCC_7,Occupational airborne particulates attributable deaths per 100'000 capita
877,OCC_8,Occupational airborne particulates attributable DALYs per 100'000 capita
878,OCC_9,Occupational carcinogens attributable deaths
879,ODA_1,"Donor commitments (Million, constant 2009 US$)"
880,ODA_2,"Commitments to recipient countries (Million, constant 2009 US$)"
881,ODA_3,"Donor disbursements (Million, constant 2009 US$)"
882,ODA_4,"Disbursements to recipient countries (Million, constant 2009 US$)"
883,ors,Children aged < 5 years with diarrhoea receiving oral rehydration salts (%)
884,ort,Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%)
885,overwgt5,Overweight prevalence in children aged <five years (%)
886,P_count_places_sf,National smoking ban: NUMBER OF PLACES SMOKE-FREE
887,P_Group,Protecting people from tobacco smoke
888,P1_compliance,Compliance of ban on smoking in HEALTH-CARE FACILITIES
889,P1_healthcare,National smoking ban in HEALTH-CARE FACILITIES
890,P10_subnat_auth_exists,Subnational smoking bans - authority exists
891,P11_fines_any,National smoking ban: FINES FOR VIOLATIONS
892,P12_fines_establishment,National smoking ban: FINES ON THE ESTABLISHMENT
893,P13_fines_smoker,National smoking ban: FINES ON THE PATRON
894,P14_funds_for_enforce,National smoking ban: DEDICATED FUNDS FOR ENFORCEMENT
895,P15_complaints,National smoking ban: CITIZEN COMPLAINTS AND INVESTIGATIONS
896,P16_subnat_complete_bans_exist,Comprehensive bans in place subnationally
897,P2_compliance,Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES
898,P2_education,National smoking ban in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES
899,P3_compliance,Compliance of ban on smoking in UNIVERSITIES
900,P3_universities,National smoking ban in UNIVERSITIES
901,P4_compliance,Compliance of ban on smoking in GOVERNMENT FACILITIES
902,P4_govt,National smoking ban in GOVERNMENT FACILITIES
903,P5_compliance,Compliance of ban on smoking in INDOOR OFFICES
904,P5_indoor_off,National smoking ban in INDOOR OFFICES
905,P6_compliance,Compliance of ban on smoking in RESTAURANTS
906,P6_restaurants,National smoking ban in RESTAURANTS
907,P7_compliance,Compliance of ban on smoking in PUBS AND BARS
908,P7_pubs,National smoking ban in PUBS AND BARS
909,P8_compliance,Compliance of ban on smoking in PUBLIC TRANSPORT
910,P8_pub_transp,National smoking ban in PUBLIC TRANSPORT
911,P9_all_other,National smoking ban in ALL OTHER INDOOR PUBLIC PLACES
912,PC_sfe_compliance,Compliance with regulations on smoke-free environments (national legislation)
913,PCV3,Pneumoccocal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)
914,PercposANC,Antenatal care attendees who were positive for syphilis (%)
915,PerctestedANC,Women accessing antenatal care (ANC) services who were tested for syphilis (%)
916,PerctreatedANC,Antenatal care attendees positive for syphilis who received treatment (%)
917,pncall,Postnatal care visit within two days of birth (in the x years preceding the survey) (%)
918,pncall3,Postnatal care visit within two days of birth (in the three years preceding the survey) (%)
919,pncall5,Postnatal care visit within two days of birth (in the five years preceding the survey) (%)
920,pnchome,Postnatal care visit within two days of birth - born outside a health facility (in the x years preceding the survey) (%)
921,pnchome3,Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%)
922,pnchome5,Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%)
923,poliov,Polio immunization coverage among one-year-olds (%)
924,R_Ad_val_average,Average - taxes as a % of cigarette price - ad valorem excise
925,R_Ad_val_estimate,Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
926,R_admin_duty_free_allowance,"Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)"
927,R_admin_duty_free_limited,Tax administration: Bans or limits on duty free imports by travellers
928,R_admin_tax_stamps,Tax administration: Tax stamps applied on tobacco products
929,R_afford_gdp,Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand
930,R_afford_price_dispersion,Affordability: Price dispersion: share of cheapest brand price in premium brand price (the higher the % the smaller the gap)
931,R_afford_tax_auto_adjust,Affordability: Specific tax component automatically adjusted for inflation (or other)
932,R_Curr_lowest_cost,Cheapest brand of cigarettes - currency reported
933,R_Curr_mp,Most sold brand of cigarettes - currency reported
934,R_Curr_premium_cost,Premium brand of cigarettes - currency reported
935,R_excise_incr,Tobacco excises increased over the survey period
936,R_excise_min_specific,Tax structure: Minimum specific tax applied in ad valorem or mixed excise regime
937,R_excise_proportion,Tax structure: Excise tax proportion of price
938,R_excise_retail_price_base,Tax structure: Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)
939,R_excise_specific_reliance,Tax structure: Greater reliance on specific tax in mixed excise regime
940,R_excise_type,Tax structure: Type of excise tax applied
941,R_excise_uniform_varied,Tax structure: Uniform excise tax
942,R_Group,Raising taxes on tobacco
943,R_imp_duty_average,Average - taxes as a % of cigarette price - import duties
944,R_imp_duty_estimate,Most sold brand of cigarettes - taxes as a % of price - import duties
945,R_Other_average,Average - taxes as a % of cigarette price - other taxes
946,R_Other_estimate,Most sold brand of cigarettes - taxes as a % of price - other taxes
947,R_Price_mp_estimate,Most sold brand of cigarettes - price in currency reported
948,R_Price_premium_estimate,Premium brand of cigarettes - price in currency reported
949,R_Price_premium_ppp,Premium brand of cigarettes - price in international dollars
950,R_Price_premium_usd,Premium brand of cigarettes - price in US$ at official exchange rates
951,R_Sp_excise_average,Average - taxes as a % of cigarette price - specific excise
952,R_Sp_excise_estimate,Most sold brand of cigarettes - taxes as a % of price - specific excise
953,R_total_tax_average,Average - taxes as a % of cigarette price - total tax
954,R_total_tax_estimate,Most sold brand of cigarettes - taxes as a % of price - total tax
955,R_VAT_average,Average - taxes as a % of cigarette price - value added tax
956,R_VAT_estimate,Most sold brand of cigarettes - taxes as a % of price - value added tax
957,RADON_Q201,Existence of any national radon activity
958,RADON_Q301,Existence of national radon survey(s)
959,RADON_Q302,National radon concentration levels
960,RADON_Q303,Existence of national radon database
961,RADON_Q304,Data in national radon database
962,RADON_Q401,Existence of national radon action plan
963,RADON_Q402,Existence of national radon regulations
964,RADON_Q403,Radon in building regulations for new buildings
965,RADON_Q404,Radon in building regulations for existing buildings i.e. renovation/remodeling/major alteration
966,RADON_Q405,Radon in national drinking-water regulations
967,RADON_Q501,Existence of national reference level for dwellings and buildings with high public occupancy
968,RADON_Q502,Existence of national reference level for buildings with high public occupancy
969,RADON_Q601,Existence of official protocols for radon measurements
970,RADON_Q602,Radon concentration measurements for new buildings
971,RADON_Q603,Radon concentration measurements for existing buildings
972,RADON_Q604,Authorization/accreditation required for official radon measurement providers
973,RADON_Q701,Mandatory preventive measures (new buildings)
974,RADON_Q702,Mandatory mitigation measures if legal value is exceeded (existing buildings)
975,RADON_Q703,Financial support provided for mitigation (existing dwellings)
976,RADON_Q704,Authorization/accreditation required for prevention/mitigation service providers
977,RADON_Q705,Official standards/guidelines for prevention/mitigation
978,RADON_Q706,Existence of training/education on prevention/mitigation
979,RADON_Q801,Existence of national radon risk communication strategy
980,RADON_Q802,Inclusion of radon measurements in property transactions
981,RADON_Q803,Inclusion of radon in national cancer control strategy
982,RateCS,Congenital syphilis rate per 100 000 live births
983,Rev_curr,Annual tax revenues - currency
984,Rev_excise,Annual tax revenues - total excise (specific and ad valorem)
985,Rev_govt_total,Annual tax revenues - total revenues
986,Rev_imp_other,Annual tax revenues - import duties and all other taxes (excluding corporate taxes on tobacco companies)
987,Rev_type,Annual tax revenues - tobacco products included
988,Rev_VAT,Annual tax revenues - value added tax (vat) and other sales taxes
989,Rev_year,Annual tax revenues - year
990,RHR_IPV,Intimate partner violence prevalence among ever partnered women (%)
991,RHR_NPSV,Non-partner sexual violence prevalence (%)
992,ROTAC,Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)
993,RS_1845,Population
994,RS_193,Income level
995,RS_194,Number of registered vehicles
996,RS_196,Estimated number of road traffic deaths
997,RS_198,Estimated road traffic death rate (per 100 000 population)
998,RS_204,Existence of a national drink-driving law
999,RS_205,Definition of drink-driving by BAC
1000,RS_207,Blood Alcohol Concentration (BAC) limit for drivers
1001,RS_208,Attribution of road traffic deaths to alcohol (%)
1002,RS_209,Existence of a national seat-belt law
1003,RS_210,Applicability of seat-belt law to all occupants
1004,RS_212,Seat-belt wearing rate (%)
1005,RS_213,Existence of a national child-restraint law
1006,RS_214,Existence of national speed limits
1007,RS_217,Maximum speed limits
1008,RS_219,Applicability of national motorcycle helmet law to all occupants
1009,RS_223_BIS,Law requires helmet to be fastened
1010,RS_225,Existence of a road safety lead agency
1011,RS_228,Existence of a national road safety strategy
1012,RS_229,Availability of funding for national road safety strategy
1013,RS_237,Existence of a formal pre-hospital care system
1014,RS_238,Existence of a universal access telephone number for pre-hospital care
1015,RS_242,Vehicle standards
1016,RS_246,Distribution of road traffic deaths by type of road user (%)
1017,RS_576,Gross national income per capita (Atlas method)
1018,RSUD_1,"Point prevalence (%), alcohol use disorders, 15+ years"
1019,RSUD_10,National survey on substance use among children and adolescents
1020,RSUD_100,Government unit/official responsible for prevention for substance use
1021,RSUD_11,Data on substance use disorders disseminated in national annual reports
1022,RSUD_110,Ministry/office that takes primary responsibility for prevention for substance use
1023,RSUD_12,Substance use policy at the national level
1024,RSUD_120,Five years change in international cooperation for prevention for substance use
1025,RSUD_13,"Substance use policy at the national level, level of integration"
1026,RSUD_130,Government unit/official responsible for treatment of substance use disorders
1027,RSUD_14,Policy documents on the pharmacological treatment of substance use disorders
1028,RSUD_140,Ministry/office that takes primary responsibility for treatment of substance use disorders
1029,RSUD_15,Guidelines on the pharmacological treatment of substance use disorders
1030,RSUD_150,Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders
1031,RSUD_16,Legislative provision for treatment and rehabilitation of substance use disorders
1032,RSUD_160,Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders
1033,RSUD_17,Legislative provision for compulsory treatment
1034,RSUD_170,Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs
1035,RSUD_18,Drug courts
1036,RSUD_180,Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs
1037,RSUD_19,Programmes diverting clients from the justice system towards treatment
1038,RSUD_190,Five years change in international cooperation for treatment of substance use disorders
1039,RSUD_2,"Point prevalence (%), drug use disorders, 15+ years"
1040,RSUD_20,Confidentiality of health records on substance use disorders  protected by law
1041,RSUD_200,Confidentiality of people in treatment for substance use disorders
1042,RSUD_21,Government unit for substance use disorder treatment
1043,RSUD_210,Voluntary treatment for people with alcohol use disorders in the criminal justice system
1044,RSUD_22,Budget line for substance use disorder treatment
1045,RSUD_220,Voluntary treatment for people with drug use disorders in the criminal justice system
1046,RSUD_23,Financing method for substance use disorder treatment
1047,RSUD_230,Compulsory treatment for people with alcohol use disorders in the criminal justice system
1048,RSUD_240,Compulsory treatment for people with drug use disorders in the criminal justice system
1049,RSUD_250,Five-year change in government resources for prevention for substance use
1050,RSUD_26,Governement benefits for persons with substance use disorders
1051,RSUD_260,Five-year change in government resources for treatment of substance use disorders
1052,RSUD_27,"Government benefits for alcohol use disorders, subsidy or disability pension"
1053,RSUD_270,Financing methods for treatment for alcohol use disorders
1054,RSUD_28,"Government benefits for drug use disorders, subsidy or disability pension"
1055,RSUD_280,Financing methods for treatment for drug use disorders
1056,RSUD_29,Sector for inpatient detoxification of alcohol use disorders
1057,RSUD_290,Hypothecated taxes to be spent on prevention and treatment for substance use disorders
1058,RSUD_3,"Age-standardized death rates, alcohol and drug use disorders, per 100 000"
1059,RSUD_30,Sector for inpatient treatment of alcohol dependence
1060,RSUD_300,Government benefits for people with alcohol use disorders
1061,RSUD_31,Sector for outpatient treatment of alcohol dependence
1062,RSUD_310,Government benefits for people with drug use disorders
1063,RSUD_32,Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions
1064,RSUD_320,Main sector for treatment for alcohol use disorders
1065,RSUD_33,Sector for residential long-term rehabilitation of alcohol use disorders
1066,RSUD_330,Main sector for treatment for drug use disorders
1067,RSUD_34,Sector for inpatient detoxification of drug use disorders
1068,RSUD_340,Treatment programmes for children and adolescents with alcohol use disorders
1069,RSUD_35,Sector for inpatient treatment of drug dependence
1070,RSUD_350,Treatment programmes for children and adolescents with drug use disorders
1071,RSUD_36,Sector for outpatient treatment of drug dependence
1072,RSUD_360,Specialized treatment facilities for substance use disorders
1073,RSUD_37,Sector for substitution maintenance therapy of opioid dependence
1074,RSUD_370,Specialized treatment facilities for alcohol use disorders
1075,RSUD_38,Sector for residential long-term rehabilitation of drug use disorders
1076,RSUD_380,Specialized treatment facilities for drug use disorders
1077,RSUD_39,Treatment system for substance use disorders
1078,RSUD_390,Self-help groups
1079,RSUD_40,"Treatment setting for substance use disorders, most common"
1080,RSUD_400,Main substance at treatment entry
1081,RSUD_41,Specialized treatment services for drug use disoders and HIV/AIDS
1082,RSUD_410,Reported treatment coverage for substance dependence
1083,RSUD_42,Specialized treatment services for substance use disorders and TB
1084,RSUD_420,Guidelines on pharmacological treatment for substance use disorders
1085,RSUD_43,Open access services for substance use disorders
1086,RSUD_430,Pharmacotherapy with methadone
1087,RSUD_44,"Treatment slots for alcohol and drug use disorders, outpatient, per 10 000"
1088,RSUD_440,Pharmacotherapy with buprenorphine
1089,RSUD_45,"Beds for the treatment of substance use disorders, per 100 000"
1090,RSUD_450,Pharmacotherapy with buprenorphine/naloxone
1091,RSUD_46,"Length of stay for inpatient detoxification, days"
1092,RSUD_460,Access restrictions to maintenance treatment
1093,RSUD_47,"Length of stay for inpatient short-term treatment, days"
1094,RSUD_470,Timeframe for maintenance treatment of opioid dependence
1095,RSUD_48,"Length of stay for inpatient long-term residential treatment, days"
1096,RSUD_480,Registration of medications for alcohol dependence and withdrawal
1097,RSUD_49,Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)
1098,RSUD_490,Registration of medications for opioid dependence
1099,RSUD_5,"Age-standardized DALYs, alcohol and drug use disorders, per 100 000"
1100,RSUD_50,Timeframe of opioid agonist treatment
1101,RSUD_500,Registration of medications for opioid withdrawal
1102,RSUD_51,Methadone used for the treatment of opioid dependence
1103,RSUD_510,Registration of naloxone for injection for opioid overdose
1104,RSUD_52,Methadone used for detoxification or maintenance
1105,RSUD_520,Availability of naloxone
1106,RSUD_53,Methadone formulation used for the treatment of opiod dependence
1107,RSUD_530,Screening and brief intervention for substance use in primary health care
1108,RSUD_54,Buprenorphine used for the treatment of opioid dependence
1109,RSUD_540,Screening and brief intervention for substance use in antenatal services
1110,RSUD_55,Buprenorphine used for detoxification or maintenance
1111,RSUD_550,Recommendations for screening and brief interventions for substance use in primary health care
1112,RSUD_56,Buprenorphine/naloxone used for the treatment of opioid dependence
1113,RSUD_560,Recommendations for screening and brief interventions for substance use in antenatal services
1114,RSUD_57,Buprenorphine/naloxone used for detoxification or maintenance
1115,RSUD_570,Groups and agencies involved in prevention programs
1116,RSUD_58,Methadone provision in clinical and community-based settings
1117,RSUD_580,Prevention programmes for alcohol
1118,RSUD_59,Buprenorphine provision in clinical and community-based settings
1119,RSUD_590,Prevention programmes for specific populations for alcohol
1120,RSUD_60,Buprenorphine/naloxone provision in clinical and community-based settings
1121,RSUD_600,Prevention programmes for drugs
1122,RSUD_61,Supervision requirements for methadone administration
1123,RSUD_610,Prevention programmes for specific populations for drugs
1124,RSUD_62,Supervision requirements for buprenorphine administration
1125,RSUD_620,"HIV, Hepatitis counselling and treatment availability in specialized facilities and services"
1126,RSUD_63,Supervision requirements for buprenorphine/naloxone administration
1127,RSUD_630,Programmes readily available
1128,RSUD_64,Prescription requirements for methadone
1129,RSUD_640,Standards of treatment and care for public specialized treatment facilities
1130,RSUD_65,Prescription requirements for buprenorphine
1131,RSUD_650,Special treatment programmes for gambling disorder
1132,RSUD_66,Prescription requirements for buprenorphine/naloxone
1133,RSUD_660,Treatment programmes for women with alcohol use disorders
1134,RSUD_67,Commencement of treatment with opioid agonists
1135,RSUD_670,Treatment programmes for women with drug use disorders
1136,RSUD_68,Pharmacotherapy used for the management of alcohol withdrawal
1137,RSUD_680,Special housing services for alcohol use disorders
1138,RSUD_69,Pharmacotherapy used for the management of benzodiazepine withdrawal
1139,RSUD_690,Special housing services for drug use disorders
1140,RSUD_7,Psychoactive substance causing entry into treatment
1141,RSUD_70,Pharmacotherapy used for the management of cannabis withdrawal
1142,RSUD_700,Employment services for alcohol use disorders
1143,RSUD_71,Essential list of medicines
1144,RSUD_710,Employment services for drug use disorders
1145,RSUD_72,"Essential list of medicines, pharmacotherapy for substance use disorders"
1146,RSUD_720,Open access interventions for alcohol
1147,RSUD_73,Government unit for substance use disorder prevention
1148,RSUD_730,Open access interventions for drugs
1149,RSUD_74,Budget line for substance use disorder prevention
1150,RSUD_740,Health professionals providing treatment for alcohol and drug use disorders
1151,RSUD_75,Funding method for substance use disorder prevention
1152,RSUD_750,Standards of care for professionals providing treatment for alcohol and drug use disorders
1153,RSUD_76,"Prevention activities for substance use disorders, main focus"
1154,RSUD_760,Educational attainment in prevention
1155,RSUD_77,Programmes for the prevention of substance use disorders for special populations
1156,RSUD_770,Postgraduate training programme in prevention
1157,RSUD_78,Screening and brief interventions for substance use and substance use disorders
1158,RSUD_780,Continuing professional development in prevention
1159,RSUD_79,Harm reduction programmes for IDUs
1160,RSUD_790,Educational attainment in treatment
1161,RSUD_8,Epidemiological data collection system for substance use disorders
1162,RSUD_80,Health professionals mostly involved in treatment of substance use disorders
1163,RSUD_800,Postgraduate training programme in treatment
1164,RSUD_81,Clinical supervision of health care staff
1165,RSUD_810,Continuing professional development in treatment
1166,RSUD_82,Standards of care for health professionals
1167,RSUD_820,Epidemiological data collection for substance use
1168,RSUD_83,"Standards of care for health professionals, maintenance"
1169,RSUD_830,Service delivery data collection for substance use
1170,RSUD_84,"Standards of care for health professionals, human rights"
1171,RSUD_840,Regular reports on epidemiological and service delivery data for substance use
1172,RSUD_85,NGOs for alcohol use disorders
1173,RSUD_850,System of monitoring alcohol involvement in forensic pathology
1174,RSUD_86,NGOs for drug use disorders
1175,RSUD_860,System of monitoring drugs involvement in forensic pathology
1176,RSUD_87,Self-help groups for substance use disorders
1177,RSUD_870,Epidemiological data collection system for substance use among children and adolescents
1178,RSUD_88,Groups and agencies for the prevention of substance use disorders
1179,RSUD_880,Epidemiological data collection system for substance use among children and adolescents
1180,RSUD_89,Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)
1181,RSUD_890,Treatment programmes for children and adolescents with alcohol use disorders
1182,RSUD_9,Service delivery data collection system for substance use disorders
1183,RSUD_900,Treatment programmes for children and adolescents with drug use disorders
1184,SA_0000001398,"Alcohol, consumption of pure alcohol by type of beverage (%)"
1185,SA_0000001398_ARCHIVED,"Alcohol, consumption of pure alcohol by type of beverage (%)"
1186,SA_0000001400,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)"
1187,SA_0000001400_ARCHIVED,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)"
1188,SA_0000001401,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average"
1189,SA_0000001401_ARCHIVED,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average"
1190,SA_0000001402,"Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010"
1191,SA_0000001402_ARCHIVED,"Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010"
1192,SA_0000001403,"Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)"
1193,SA_0000001403_ARCHIVED,"Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)"
1194,SA_0000001404,"Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol"
1195,SA_0000001404_ARCHIVED,"Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol"
1196,SA_0000001405,"Alcohol, tourist consumption (in litres of pure alcohol)"
1197,SA_0000001405_ARCHIVED,"Alcohol, tourist consumption (in litres of pure alcohol)"
1198,SA_0000001406,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)"
1199,SA_0000001406_ARCHIVED,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)"
1200,SA_0000001409,"Alcohol, abstainers lifetime (%)"
1201,SA_0000001409_ARCHIVED,"Alcohol, abstainers lifetime (%)"
1202,SA_0000001410,"Abstainers (15-19 years), lifetime (%)"
1203,SA_0000001411,"Alcohol, abstainers past 12 months (%)"
1204,SA_0000001411_ARCHIVED,"Alcohol, abstainers past 12 months (%)"
1205,SA_0000001412,"Abstainers (15-19 years), past 12 months (%)"
1206,SA_0000001413,"Alcohol, consumers past 12 months (%)"
1207,SA_0000001413_ARCHIVED,"Alcohol, consumers past 12 months (%)"
1208,SA_0000001414,"Alcohol, former drinkers (%)"
1209,SA_0000001414_ARCHIVED,"Alcohol, former drinkers (%)"
1210,SA_0000001415_ARCHIVED,"Alcohol, heavy episodic drinking (population) past 30 days (%)"
1211,SA_0000001416,"Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)"
1212,SA_0000001416_ARCHIVED,"Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)"
1213,SA_0000001417,"Alcohol, patterns of drinking score"
1214,SA_0000001417_ARCHIVED,"Alcohol, patterns of drinking score"
1215,SA_0000001418,"Age-standardized DALYs, alcohol use disorders, per 100,000"
1216,SA_0000001419,"Age-standardized DALYs, breast cancer, per 100,000"
1217,SA_0000001420,"Age-standardized DALYs, colon and rectum cancers, per 100,000"
1218,SA_0000001421,"Age-standardized DALYs, diabetes mellitus, per 100,000"
1219,SA_0000001422,"Age-standardized DALYs, drownings, per 100,000"
1220,SA_0000001423,"Age-standardized DALYs, falls, per 100,000"
1221,SA_0000001424,"Age-standardized DALYs, fires, per 100,000"
1222,SA_0000001425,"Age-standardized DALYs, ischaemic heart disease, per 100,000"
1223,SA_0000001426,"Age-standardized DALYs, liver cancer, per 100,000"
1224,SA_0000001427,"Age-standardized DALYs, liver cirrhosis, per 100,000"
1225,SA_0000001429,"Age-standardized DALYs, mouth and oropharynx cancer, per 100,000"
1226,SA_0000001430,"Age-standardized DALYs, oesophagus cancer, per 100,000"
1227,SA_0000001431,"Age-standardized DALYs, poisoning, per 100,000"
1228,SA_0000001432,"Age-standardized DALYs, prematurity and low birth rate, per 100,000"
1229,SA_0000001433,"Age-standardized DALYs, road traffic accidents, per 100,000"
1230,SA_0000001434,"Age-standardized DALYs, self-inflicted injury, per 100,000"
1231,SA_0000001435,"Age-standardized DALYs, other unintentional injuries, per 100,000"
1232,SA_0000001436,"Age-standardized DALYs, violence, per 100,000"
1233,SA_0000001437,"Age-standardized death rates, alcohol use disorders, per 100,000"
1234,SA_0000001438,"Age-standardized death rates, breast cancer, per 100,000"
1235,SA_0000001439,"Age-standardized death rates, colon and rectum cancers, per 100,000"
1236,SA_0000001440,"Age-standardized death rates, diabetes mellitus, per 100,000"
1237,SA_0000001441,"Age-standardized death rates, drownings, per 100,000"
1238,SA_0000001442,"Age-standardized death rates, falls, per 100,000"
1239,SA_0000001443,"Age-standardized death rates, fires, per 100,000"
1240,SA_0000001444,"Age-standardized death rates, ischaemic heart disease, per 100,000"
1241,SA_0000001445,"Age-standardized death rates, liver cancer, per 100,000"
1242,SA_0000001446,"Age-standardized death rates, liver cirrhosis, per 100,000"
1243,SA_0000001448,"Age-standardized death rates, mouth and oropharynx cancer, per 100,000"
1244,SA_0000001449,"Age-standardized death rates, oesophagus cancer, per 100,000"
1245,SA_0000001450,"Age-standardized death rates, poisoning, per 100,000"
1246,SA_0000001451,"Age-standardized death rates, prematurity and low birth rate, per 100,000"
1247,SA_0000001452,"Age-standardized death rates, road traffic accidents, per 100,000"
1248,SA_0000001453,"Age-standardized death rates, self-inflicted injury, per 100,000"
1249,SA_0000001454,"Age-standardized death rates, other unintentional injuries, per 100,000"
1250,SA_0000001455,"Age-standardized death rates, violence, per 100,000"
1251,SA_0000001456,"Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000"
1252,SA_0000001457,"Liver cirrhosis, age-standardized death rates (15+), per 100,000 population"
1253,SA_0000001457_ARCHIVED,"Liver cirrhosis, age-standardized death rates (15+), per 100,000 population"
1254,SA_0000001458,"Age-standardized death rates (15+ years), poisoning, per 100,000"
1255,SA_0000001459,"Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population"
1256,SA_0000001459_ARCHIVED,"Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population"
1257,SA_0000001460,"Age-standardized death rates (15+ years), violence, per 100,000"
1258,SA_0000001461,"Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI"
1259,SA_0000001461_ARCHIVED,"Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI"
1260,SA_0000001462,"Alcohol use disorders (15+), 12 month prevalence (%) with 95%"
1261,SA_0000001462_ARCHIVED,"Alcohol use disorders (15+), 12 month prevalence (%) with 95%"
1262,SA_0000001463,"Alcoholic psychosis, incidence, per 100,000"
1263,SA_0000001463_ARCHIVED,"Alcoholic psychosis, incidence, per 100,000"
1264,SA_0000001464,"Cautions and arrests for drink-driving, per 100,000 population"
1265,SA_0000001464_ARCHIVED,"Cautions and arrests for drink-driving, per 100,000 population"
1266,SA_0000001465,"Hospital discharges, alcohol-related injuries and poisoning, per 100,000"
1267,SA_0000001466,"Hospital discharges, alcoholic liver disease, per 100,000"
1268,SA_0000001467,Perceived trend in alcohol-related harm and consequences
1269,SA_0000001468,"Treatment admissions (inpatient), alcohol dependence, per 100,000"
1270,SA_0000001469,"Treatment admissions (inpatient), alcoholic psychosis, per 100,000"
1271,SA_0000001470,"Alcohol-related road traffic crashes, per 100,000 population"
1272,SA_0000001470_ARCHIVED,"Alcohol-related road traffic crashes, per 100,000 population"
1273,SA_0000001471,Alcohol-related road traffic crashes (% of all traffic crashes)
1274,SA_0000001471_ARCHIVED,Alcohol-related road traffic crashes (% of all traffic crashes)
1275,SA_0000001472,"Alcohol-related injury mortality, per 1,000"
1276,SA_0000001473,"Alcohol-related disease mortality, per 100,000 (15+ years)"
1277,SA_0000001474,Alcoholic excise tax revenue as a per cent of government revenue
1278,SA_0000001474_ARCHIVED,Alcoholic excise tax revenue as a per cent of government revenue
1279,SA_0000001475,Annual revenues from alcohol excise tax in millions US$
1280,SA_0000001475_ARCHIVED,Annual revenues from alcohol excise tax in millions US$
1281,SA_0000001476,Alcohol expenditure as a per cent of total household expenditure
1282,SA_0000001476_ARCHIVED,Alcohol expenditure as a per cent of total household expenditure
1283,SA_0000001477,Social costs of alcohol use in millions US$
1284,SA_0000001477_ARCHIVED,Social costs of alcohol use in millions US$
1285,SA_0000001502,Adopted written national policy on alcohol
1286,SA_0000001502_ARCHIVED,Adopted written national policy on alcohol
1287,SA_0000001503,Alcoholic beverage legally defined
1288,SA_0000001504,Alcohol use is banned
1289,SA_0000001504_ARCHIVED,Alcohol use is banned
1290,SA_0000001506,National legislation to prevent illegal alcohol
1291,SA_0000001506_ARCHIVED,National legislation to prevent illegal alcohol
1292,SA_0000001507,Advertising restrictions on national television
1293,SA_0000001507_ARCHIVED,Advertising restrictions on national television
1294,SA_0000001508,Advertising restrictions on cable television
1295,SA_0000001508_ARCHIVED,Advertising restrictions on cable television
1296,SA_0000001509,Advertising restrictions on national radio
1297,SA_0000001509_ARCHIVED,Advertising restrictions on national radio
1298,SA_0000001510,Advertising restrictions on local radio
1299,SA_0000001510_ARCHIVED,Advertising restrictions on local radio
1300,SA_0000001511,Advertising restrictions in print media
1301,SA_0000001511_ARCHIVED,Advertising restrictions in print media
1302,SA_0000001512,Advertising restrictions at cinemas
1303,SA_0000001512_ARCHIVED,Advertising restrictions at cinemas
1304,SA_0000001513,Advertising restrictions on billboards
1305,SA_0000001513_ARCHIVED,Advertising restrictions on billboards
1306,SA_0000001514,Advertising restrictions at point-of-sale
1307,SA_0000001514_ARCHIVED,Advertising restrictions at point-of-sale
1308,SA_0000001515,Advertising restrictions on the internet
1309,SA_0000001515_ARCHIVED,Advertising restrictions on the internet
1310,SA_0000001516,Restrictions on product placement on national television
1311,SA_0000001516_ARCHIVED,Restrictions on product placement on national television
1312,SA_0000001517,Restrictions on product placement on cable television
1313,SA_0000001517_ARCHIVED,Restrictions on product placement on cable television
1314,SA_0000001518,Age limits on-premise service
1315,SA_0000001518_ARCHIVED,Age limits on-premise service
1316,SA_0000001519,Minimum legal drinking age
1317,SA_0000001520,Legal blood alcohol concentration (BAC) limits
1318,SA_0000001521,Random breath testing (RBT) use
1319,SA_0000001521_ARCHIVED,Random breath testing (RBT) use
1320,SA_0000001523,"Prices for alcoholic beverages (average, US$)"
1321,SA_0000001523_ARCHIVED,"Prices for alcoholic beverages (average, US$)"
1322,SA_0000001525,Off-premise sales restrictions on days
1323,SA_0000001525_ARCHIVED,Off-premise sales restrictions on days
1324,SA_0000001526,Off-premise sales restrictions on hours
1325,SA_0000001526_ARCHIVED,Off-premise sales restrictions on hours
1326,SA_0000001527,Off-premise sales restrictions on places
1327,SA_0000001527_ARCHIVED,Off-premise sales restrictions on places
1328,SA_0000001528,Off-premise sales restrictions on outlet density
1329,SA_0000001528_ARCHIVED,Off-premise sales restrictions on outlet density
1330,SA_0000001529,Off-premise sales restrictions at specific events
1331,SA_0000001529_ARCHIVED,Off-premise sales restrictions at specific events
1332,SA_0000001530,Off-premise sales restrictions at petrol stations
1333,SA_0000001530_ARCHIVED,Off-premise sales restrictions at petrol stations
1334,SA_0000001531,On-premise sales restrictions on days
1335,SA_0000001531_ARCHIVED,On-premise sales restrictions on days
1336,SA_0000001532,On-premise sales restrictions on hours
1337,SA_0000001532_ARCHIVED,On-premise sales restrictions on hours
1338,SA_0000001533,On-premise sales restrictions on places
1339,SA_0000001533_ARCHIVED,On-premise sales restrictions on places
1340,SA_0000001534,On-premise sales restrictions on outlet density
1341,SA_0000001534_ARCHIVED,On-premise sales restrictions on outlet density
1342,SA_0000001535,On-premise sales restrictions at specific events
1343,SA_0000001535_ARCHIVED,On-premise sales restrictions at specific events
1344,SA_0000001536,On-premise sales restrictions to intoxicated persons
1345,SA_0000001536_ARCHIVED,On-premise sales restrictions to intoxicated persons
1346,SA_0000001537,Restrictions on sponsorship of sporting events
1347,SA_0000001537_ARCHIVED,Restrictions on sponsorship of sporting events
1348,SA_0000001538,Restrictions on sponsorship of youth events
1349,SA_0000001538_ARCHIVED,Restrictions on sponsorship of youth events
1350,SA_0000001539,"Restrictions on sales promotion from producers (parties, events)"
1351,SA_0000001539_ARCHIVED,"Restrictions on sales promotion from producers (parties, events)"
1352,SA_0000001540,Restrictions on sales promotion from retailers (sales below cost)
1353,SA_0000001540_ARCHIVED,Restrictions on sales promotion from retailers (sales below cost)
1354,SA_0000001541,Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
1355,SA_0000001541_ARCHIVED,Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
1356,SA_0000001542,Government monopoly on production
1357,SA_0000001542_ARCHIVED,Government monopoly on production
1358,SA_0000001543,Government monopoly on retail sales
1359,SA_0000001543_ARCHIVED,Government monopoly on retail sales
1360,SA_0000001544,Licence required for production
1361,SA_0000001544_ARCHIVED,Licence required for production
1362,SA_0000001545,Licence required for retail sales
1363,SA_0000001545_ARCHIVED,Licence required for retail sales
1364,SA_0000001546,Excise tax as a per cent of the retail price of alcoholic beverages
1365,SA_0000001546_ARCHIVED,Excise tax as a per cent of the retail price of alcoholic beverages
1366,SA_0000001547,Excise duty (average) per hectolitre in Euros
1367,SA_0000001547_ARCHIVED,Excise duty (average) per hectolitre in Euros
1368,SA_0000001548,Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
1369,SA_0000001548_ARCHIVED,Excise tax as a per cent of the total retail price for 1 litre of pure alcohol
1370,SA_0000001549,Duty paid or excise stamp on alcohol container
1371,SA_0000001549_ARCHIVED,Duty paid or excise stamp on alcohol container
1372,SA_0000001550,Excise tax on alcoholic beverages
1373,SA_0000001550_ARCHIVED,Excise tax on alcoholic beverages
1374,SA_0000001551,Value-added tax (VAT) on alcohol (%)
1375,SA_0000001551_ARCHIVED,Value-added tax (VAT) on alcohol (%)
1376,SA_0000001553,Restrictions on alcohol use in public places
1377,SA_0000001553_ARCHIVED,Restrictions on alcohol use in public places
1378,SA_0000001554,Health warning labels on alcohol advertising
1379,SA_0000001554_ARCHIVED,Health warning labels on alcohol advertising
1380,SA_0000001555,Health warning labels on alcohol containers
1381,SA_0000001555_ARCHIVED,Health warning labels on alcohol containers
1382,SA_0000001647,Awareness activities
1383,SA_0000001647_ARCHIVED,Awareness activities
1384,SA_0000001648,"Information, education, prevention"
1385,SA_0000001649,National drinking guidelines
1386,SA_0000001650,"Standard drink measures, in grams per unit"
1387,SA_0000001650_ARCHIVED,"Standard drink measures, in grams per unit"
1388,SA_0000001651,Monitoring
1389,SA_0000001652,"Interventions, projects, training"
1390,SA_0000001653,"Treatment, services"
1391,SA_0000001654,"Surveys, research"
1392,SA_0000001655,Counselling
1393,SA_0000001676,Production in 1000s hectolitres
1394,SA_0000001677,Imports in 1000s hectolitres
1395,SA_0000001678,Sales of beer in 1000s hectolitres
1396,SA_0000001679,Exports of beer (barley) in 1000s hectolitres
1397,SA_0000001680,Perceived trend in production
1398,SA_0000001681,Perceived trend in imports
1399,SA_0000001682,Perceived trend in sales
1400,SA_0000001683,Perceived trend in exports
1401,SA_0000001684,Sales of wine in 1000s hectolitres
1402,SA_0000001685,Sales of spirits in 1000s hectolitres
1403,SA_0000001686,Exports of wine (grape) in 1000s hectolitres
1404,SA_0000001687,Exports of spirits in 1000s hectolitres
1405,SA_0000001688,"Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)"
1406,SA_0000001688_ARCHIVED,Total (recorded+unrecorded) alcohol per capita (15+) consumption
1407,SA_0000001689,"Age-standardized DALYs, cerebrovascular disease, per 100,000"
1408,SA_0000001690,"Age-standardized death rates, cerebrovascular disease, per 100,000"
1409,SA_0000001691,Central coordinating entity for alcohol policy implementation
1410,SA_0000001691_ARCHIVED,Central coordinating entity for alcohol policy implementation
1411,SA_0000001692,Framework of national alcohol policy
1412,SA_0000001692_ARCHIVED,Framework of national alcohol policy
1413,SA_0000001693,Level of adoption of national alcohol policy
1414,SA_0000001693_ARCHIVED,Level of adoption of national alcohol policy
1415,SA_0000001694,Sectors represented in national alcohol policy
1416,SA_0000001694_ARCHIVED,Sectors represented in national alcohol policy
1417,SA_0000001695,"Cautions and arrests for public drunkenness, per 100,000 population"
1418,SA_0000001695_ARCHIVED,"Cautions and arrests for public drunkenness, per 100,000 population"
1419,SA_0000001696,Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)
1420,SA_0000001696_ARCHIVED,Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)
1421,SA_0000001697,"Adopted written national policy on alcohol, year adopted"
1422,SA_0000001698,"Adopted written national policy on alcohol, year revised"
1423,SA_0000001699,Age limits off-premise sales
1424,SA_0000001699_ARCHIVED,Age limits off-premise sales
1425,SA_0000001700,Consumer information on alcohol and health at points of sale
1426,SA_0000001701,Educational programmes involving target groups in school curriculum
1427,SA_0000001702,Brief interventions as health promotion/disease prevention
1428,SA_0000001703,Server training on a regular basis
1429,SA_0000001704,Data collection on alcohol-related health indicators
1430,SA_0000001705,System for monitoring alcohol-related harm
1431,SA_0000001706,National treatment policy for alcohol use disorders
1432,SA_0000001707,Persons with alcohol use disorders receiving treatment (%)
1433,SA_0000001708,Designation of alcohol tax revenues to health services
1434,SA_0000001709,National surveys on drink-driving
1435,SA_0000001710,Public-funded alcohol research/monitoring programmes
1436,SA_0000001711,"Public funds designated for alcohol research/monitoring programmes, in Euros"
1437,SA_0000001712,Community-based interventions/projects involving stakeholders
1438,SA_0000001713,Interventions/projects actively involving young people and civil society
1439,SA_0000001714,Training in screening and brief interventions for alcohol problems
1440,SA_0000001715,Counselling to children in families with alcohol problems
1441,SA_0000001716,Counselling to pregnant women with alcohol problems
1442,SA_0000001717,Prevention/counselling at workplaces for those with alcohol problems
1443,SA_0000001719,Advertising restrictions on social media
1444,SA_0000001719_ARCHIVED,Advertising restrictions on social media
1445,SA_0000001720,Restrictions on product placement in films/movies
1446,SA_0000001720_ARCHIVED,Restrictions on product placement in films/movies
1447,SA_0000001721,Importance of measures for enhancing compliance with age limits
1448,SA_0000001721_ARCHIVED,Importance of measures for enhancing compliance with age limits
1449,SA_0000001722,Government support for community action
1450,SA_0000001722_ARCHIVED,Government support for community action
1451,SA_0000001723,Community-based interventions involving stakeholders
1452,SA_0000001723_ARCHIVED,Community-based interventions involving stakeholders
1453,SA_0000001724,National guidelines for implementing effective community-based interventions
1454,SA_0000001724_ARCHIVED,National guidelines for implementing effective community-based interventions
1455,SA_0000001725,National alcohol policy specifically involves young people activities
1456,SA_0000001725_ARCHIVED,National alcohol policy specifically involves young people activities
1457,SA_0000001726,Penalties for drink driving
1458,SA_0000001726_ARCHIVED,Penalties for drink driving
1459,SA_0000001727,Sobriety checkpoints
1460,SA_0000001727_ARCHIVED,Sobriety checkpoints
1461,SA_0000001728,Detection of marketing infringements
1462,SA_0000001728_ARCHIVED,Detection of marketing infringements
1463,SA_0000001729,Penalties for marketing infringements
1464,SA_0000001730,Price measures
1465,SA_0000001730_ARCHIVED,Price measures
1466,SA_0000001731,Level of taxation adjusted for inflation
1467,SA_0000001731_ARCHIVED,Level of taxation adjusted for inflation
1468,SA_0000001732,New types of alcoholic beverages emerging
1469,SA_0000001732_ARCHIVED,New types of alcoholic beverages emerging
1470,SA_0000001733,"Consumer information about calories, additives, etc on containers"
1471,SA_0000001733_ARCHIVED,"Consumer information about calories, additives, etc on containers"
1472,SA_0000001734,Number of standard alcoholic drinks displayed on containers
1473,SA_0000001734_ARCHIVED,Number of standard alcoholic drinks displayed on containers
1474,SA_0000001735,Alcohol content displayed on containers
1475,SA_0000001735_ARCHIVED,Alcohol content displayed on containers
1476,SA_0000001736,Action Plan for implementation of alcohol policy
1477,SA_0000001736_ARCHIVED,Action Plan for implementation of alcohol policy
1478,SA_0000001737,"Alcohol, regional per capita (15+) consumption (in litres of pure alcohol)"
1479,SA_0000001737_ARCHIVED,"Alcohol, regional per capita (15+) consumption (in litres of pure alcohol)"
1480,SA_0000001739,"Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI"
1481,SA_0000001739_ARCHIVED,"Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI"
1482,SA_0000001740,Alcohol-attributable Years of Life Lost (YLL) score
1483,SA_0000001741,"Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)"
1484,SA_0000001741_ARCHIVED,"Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)"
1485,SA_0000001742,"Alcohol-attributable fractions (15+), road traffic crash deaths (%)"
1486,SA_0000001742_ARCHIVED,"Alcohol-attributable fractions (15+), road traffic crash deaths (%)"
1487,SA_0000001743,"Alcohol-attributable fractions, all-cause deaths (%)"
1488,SA_0000001743_ARCHIVED,"Alcohol-attributable fractions, all-cause deaths (%)"
1489,SA_0000001744,"Alcohol, regional prevalence of alcohol dependence (%)"
1490,SA_0000001744_ARCHIVED,"Alcohol, regional prevalence of alcohol dependence (%)"
1491,SA_0000001745,"Alcohol, regional prevalence of alcohol use disorders (%)"
1492,SA_0000001745_ARCHIVED,"Alcohol, regional prevalence of alcohol use disorders (%)"
1493,SA_0000001746,"Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025"
1494,SA_0000001746_ARCHIVED,"Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025"
1495,SA_0000001747_ARCHIVED,"Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI"
1496,SA_0000001748,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
1497,SA_0000001748_ARCHIVED,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
1498,SA_0000001749,"Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
1499,SA_0000001749_ARCHIVED,"Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
1500,SA_0000001751,"Alcohol, average daily intake in grams among drinkers with 95%CI"
1501,SA_0000001751_ARCHIVED,"Alcohol, average daily intake in grams among drinkers with 95%CI"
1502,SA_0000001752,"Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016"
1503,SA_0000001752_ARCHIVED,"Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016"
1504,SA_0000001753_ARCHIVED,"Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI"
1505,SA_0000001754,"Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI"
1506,SA_0000001754_ARCHIVED,"Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI"
1507,SA_0000001755,"15-19 years old heavy episodic drinkers (population), % with 95%CI"
1508,SA_0000001755_ARCHIVED,"15-19 years old heavy episodic drinkers (population), % with 95%CI"
1509,SA_0000001756,"15-19 years old heavy episodic drinkers (drinkers only), %"
1510,SA_0000001757,"15-19 years old abstainers, lifetime (%)"
1511,SA_0000001757_ARCHIVED,"15-19 years old abstainers, lifetime (%)"
1512,SA_0000001758,15-19 years old former drinkers (%)
1513,SA_0000001758_ARCHIVED,15-19 years old former drinkers (%)
1514,SA_0000001759,"15-19 years old, current drinkers (%)"
1515,SA_0000001759_ARCHIVED,"15-19 years old, current drinkers (%)"
1516,SA_0000001760,15-19 years old total alcohol consumption in litres of pure alcohol
1517,SA_0000001760_ARCHIVED,15-19 years old total alcohol consumption in litres of pure alcohol
1518,SA_0000001761,National guidelines for the prevention and reduction of alcohol-related harm in schools
1519,SA_0000001762,National guidelines for alcohol problem prevention and counselling at workplaces
1520,SA_0000001762_ARCHIVED,National guidelines for alcohol problem prevention and counselling at workplaces
1521,SA_0000001763,Workplace representatives nationally involved to prevent and address alcohol-related harm
1522,SA_0000001763_ARCHIVED,Workplace representatives nationally involved to prevent and address alcohol-related harm
1523,SA_0000001764,Server training
1524,SA_0000001764_ARCHIVED,Server training
1525,SA_0000001765,Legal obligation for schools to include alcohol use prevention
1526,SA_0000001765_ARCHIVED,Legal obligation for schools to include alcohol use prevention
1527,SA_0000001766,Legal obligation for schools to interact with parents regarding education and well-being
1528,SA_0000001766_ARCHIVED,Legal obligation for schools to interact with parents regarding education and well-being
1529,SA_0000001767,Legislation on alcohol testing at workplaces
1530,SA_0000001767_ARCHIVED,Legislation on alcohol testing at workplaces
1531,SA_0000001768,Standard drink defined
1532,SA_0000001768_ARCHIVED,Standard drink defined
1533,SA_0000001769,National systems for monitoring alcohol consumption and harms
1534,SA_0000001769_ARCHIVED,National systems for monitoring alcohol consumption and harms
1535,SA_0000001770,Regular reports from national monitoring systems
1536,SA_0000001770_ARCHIVED,Regular reports from national monitoring systems
1537,SA_0000001771,Comprehensive and regular reporting of alcohol situation
1538,SA_0000001771_ARCHIVED,Comprehensive and regular reporting of alcohol situation
1539,SA_0000001772,Clinical guidelines for brief interventions
1540,SA_0000001772_ARCHIVED,Clinical guidelines for brief interventions
1541,SA_0000001773,National surveys on adult alcohol consumption
1542,SA_0000001773_ARCHIVED,National surveys on adult alcohol consumption
1543,SA_0000001774,National surveys on youth alcohol consumption
1544,SA_0000001774_ARCHIVED,National surveys on youth alcohol consumption
1545,SA_0000001775,National surveys on heavy espisodic drinking
1546,SA_0000001775_ARCHIVED,National surveys on heavy espisodic drinking
1547,SA_0000001776,Data collection on Foetal Alcohol Syndome
1548,SA_0000001776_ARCHIVED,Data collection on Foetal Alcohol Syndome
1549,SA_0000001777,Data collected on harm from alcohol at workplace
1550,SA_0000001777_ARCHIVED,Data collected on harm from alcohol at workplace
1551,SA_0000001779,Level of enforcement of BAC limits
1552,SA_0000001781,"15-years old any alcoholic beverage consumed in past 12 months, (%)"
1553,SA_0000001781_ARCHIVED,"15-years old any alcoholic beverage consumed in past 12 months, (%)"
1554,SA_0000001782,"15-years old first drink at 13 years or younger, (%)"
1555,SA_0000001782_ARCHIVED,"15-years old first drink at 13 years or younger, (%)"
1556,SA_0000001783,"15-years old any alcoholic beverage consumed in past 30 days, (%)"
1557,SA_0000001783_ARCHIVED,"15-years old any alcoholic beverage consumed in past 30 days, (%)"
1558,SA_0000001784,"15-years old, any alcoholic beverage consumed at least once a week, (%)"
1559,SA_0000001784_ARCHIVED,"15-years old, any alcoholic beverage consumed at least once a week, (%)"
1560,SA_0000001786,"13-15-years old any alcoholic beverage consumed in past 30 days, (%)"
1561,SA_0000001786_ARCHIVED,"13-15-years old any alcoholic beverage consumed in past 30 days, (%)"
1562,SA_0000001787,"13-15-years old first drink before age 14, (%)"
1563,SA_0000001787_ARCHIVED,"13-15-years old first drink before age 14, (%)"
1564,SA_0000001788,"Alcohol-related road traffic crashes with fatalities, per 100,000  population"
1565,SA_0000001788_ARCHIVED,"Alcohol-related road traffic crashes with fatalities, per 100,000  population"
1566,SA_0000001789,Alcohol-related crimes (% of all crimes)
1567,SA_0000001789_ARCHIVED,Alcohol-related crimes (% of all crimes)
1568,SA_0000001790,National drinking guidelines
1569,SA_0000001791,Graduated licensing
1570,SA_0000001792,National legislation to prevent illegal alcohol sales
1571,SA_0000001793,"Penalties for drink driving, repeated offense"
1572,SA_0000001794,Licensing required for exports of alcoholic beverages
1573,SA_0000001795,Licensing required for imports of alcoholic beverages
1574,SA_0000001796,Licensing required for wholesale/distribution of alcoholic beverages
1575,SA_0000001797,"Licenses issued for production, change since 2010"
1576,SA_0000001798,"Licenses issued for retail sale, change since 2010"
1577,SA_0000001799,"Licenses issued for wholesale/distribution, change since 2010"
1578,SA_0000001800,Monopoly on exports of alcoholic beverages
1579,SA_0000001801,Monopoly on imports of alcoholic beverages
1580,SA_0000001802,Monopoly on wholesale /distribution of alcoholic beverages
1581,SA_0000001803,Health warning labels on pregnancy
1582,SA_0000001804,Health warning labels on under-age drinking
1583,SA_0000001805,Health warning labels on drink-driving
1584,SA_0000001806,Legal requirement for size of health warning labels
1585,SA_0000001807,"Cancer, age-standardized death rates (15+), per 100,000 population"
1586,SA_0000001808,"Alcohol-attributable fractions (15+), cancer deaths"
1587,SA_0000001809,National system of epidemiological data collection for alcohol use
1588,SA_0000001810,National system of data collection based on health service delivery
1589,SA_0000001811,Report with epidemiological data on lcohol use and AUDs
1590,SA_0000001812,Report with data from health services on alcohol use and AUDs
1591,SA_0000001813,National organization for monitoring alcohol
1592,SA_0000001814,Taxation of ethanol production
1593,SA_0000001815,Ethanol tax deducted from excise tax
1594,SA_0000001816,Tax incentives for production low/no alcohol content beer
1595,SA_0000001817,Tax incentives for production of other alcoholic beverages
1596,SA_0000001818,"Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2020 and 2025"
1597,SA_0000001819,Heavy episodic drinking (youth 15 -19 years) past 30 days (%)
1598,SA_0000001820,"Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%)"
1599,SA_0000001821,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
1600,SA_0000001821_ARCHIVED,"Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
1601,SA_0000001822,"Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
1602,SA_0000001822_ARCHIVED,"Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI"
1603,SA_0000001823,"Alcohol, tourist consumption (in litres of pure alcohol)"
1604,SA_0000001823_ARCHIVED,"Alcohol, tourist consumption (in litres of pure alcohol)"
1605,SA_0000001824,"Alcohol, regional alcohol per capita (15+) consumption (in litres of pure alcohol)"
1606,SA_0000001825,"Regional prevalence, AAFs (15+), liver cirrhosis deaths (%)"
1607,SA_0000001826,"Regional prevalence, AAFs (15+), road traffic crash deaths (%)"
1608,SA_0000001827,"Regional prevalence, AAFs (15+), cancer"
1609,SA_0000001828,"Regional prevalence, AAFs ,all-cause deaths (%)"
1610,SA_0000001829,Average price 500 mls Beer in US$
1611,SA_0000001830,Average price 750 mls Wine in US$
1612,SA_0000001831,Average price 500 mls Spirits in US$
1613,sba,Births attended by skilled health personnel (in the two or three years preceding the survey) (%)
1614,sba5,Births attended by skilled health personnel (in the five years preceding the survey) (%)
1615,SDG_SH_DTH_RNCOM,"Number of deaths attributed to non-communicable diseases, by type of disease and sex"
1616,SDGAIRBOD,Ambient and household air pollution attributable death rate (per 100 000 population)
1617,SDGAIRBODA,"Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized)"
1618,SDGCODCOMPLETENESS,Completeness of cause-of-death data (%)
1619,SDGCONFLICT,Estimated direct deaths from major conflicts (per 100 000 population)
1620,SDGDISASTER,Average death rate due to natural disasters (per 100 000 population)
1621,SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%)
1622,SDGHIV,New HIV infections (per 1000 uninfected population)
1623,SDGIHR,Average of 13 International Health Regulations core capacity scores
1624,SDGNTDTREATMENT,Reported number of people requiring interventions against NTDs
1625,SDGODA,"Total net official development assistance to medical research and basic health sectors per capita (constant 2014 US$), by recipient"
1626,SDGODA01,"Total net official development assistance to medical research and basic health sectors per capita (US$), by recipient country"
1627,SDGPM25,Concentrations of fine particulate matter (PM2.5)
1628,SDGPOISON,Mortality rate attributed to unintentional poisoning (per 100 000 population)
1629,SDGSHP,Skilled health professionals density (per 10 000 population)
1630,SDGSUICIDE,Crude suicide rates (per 100 000 population)
1631,SDGWSHBOD,Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2)
1632,SE_DEV_ONTRK,"Children aged 36-59 months who are developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning (%)"
1633,SE_G23_MATH,Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%)
1634,SE_G23_RDG,Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%)
1635,SE_LSC_MATH,Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%)
1636,SE_LSC_RDNG,Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%)
1637,SE_PRE_PARTN,Participation rate in organized learning (one year before the official primary entry age) (%)
1638,SE_PRM_MATH,Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%)
1639,SE_PRM_RDNG,Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%)
1640,SG_REG_CENSUS,Proportion of countries that have conducted at least one population and housing census in the last 10 years (%)
1641,SH_STA_FGMS,Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting (FMG/C) (%)
1642,SHS_1,Percentage of children under 15 years exposed to second-hand smoke
1643,SHS_10,Second-hand smoke attributable DALYs ('000) in children under 5 years
1644,SHS_11,Second-hand smoke  attributable DALYs per 100'000 children under 5 years
1645,SHS_2,Percentage of women (15+ years) exposed to second-hand smoke
1646,SHS_3,Percentage of men (15+ years) exposed to second-hand smoke
1647,SHS_4,Second-hand smoke attributable deaths
1648,SHS_5,Second-hand smoke attributable DALYs ('000)
1649,SHS_6,Second-hand smoke attributable deaths per 100'000 capita
1650,SHS_7,Second-hand smoke attributable DALYs per 100'000 capita
1651,SHS_8,Second-hand smoke attributable deaths ('000) in children under 5 years
1652,SHS_9,Second-hand smoke  attributable deaths per 100'000 children under 5 years
1653,SI_POV_DAY1,Proportion of population below the international poverty line of US$1.90 per day (%)
1654,SP_DYN_MRBF15,Proportion of women aged 20-24 years who were married or in a union by age 15 (%)
1655,SP_DYN_MRBF18,Proportion of women aged 20-24 years who were married or in a union by age 18 (%)
1656,stunt5,Stunting prevalence in children aged < 5 years (%)
1657,SUNBEDEXIST,Existence of national regulation
1658,SUNBEDEXISTSUBNATIONAL,Existence of subnational regulation
1659,SUNBEDEXISTYEAR,Year of national implementation of regulation
1660,SUNBEDREG_ACCESS,Access restrictions
1661,SUNBEDREG_CONTROL,Restriction and inspection of facilities
1662,SUNBEDREG_INFO,Information requirements
1663,SUNBEDREG_SAFETY,Safety requirements
1664,SUNBEDREG_TRAINING,Training requirements
1665,TB_1,Tuberculosis treatment coverage
1666,TB_c_dst_rlt_new_pct,New cases tested for RR-/MDR-TB (%)
1667,TB_c_dst_rlt_ret_pct,Previously treated cases tested for RR-/MDR-TB (%)
1668,TB_c_lab_cul_5m,Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)
1669,TB_c_lab_dst_5m,Laboratories providing drug susceptibility testing (DST) (per 5 million population)
1670,TB_c_lab_sm_100k,Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)
1671,TB_c_mdr_tsr,Treatment success rate for patients treated for MDR-TB (%)
1672,TB_c_mdr_tx,Cases started on MDR-TB treatment
1673,TB_c_new_snep_tsr,Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases
1674,TB_c_new_tsr,Treatment success rate: new TB cases
1675,TB_c_newinc,Tuberculosis - new and relapse cases
1676,TB_c_notified,Total number of notified TB cases
1677,TB_c_ret_tsr,Treatment success rate: previously treated TB cases
1678,TB_c_tbhiv_tsr,Treatment success rate: HIV-positive TB cases
1679,TB_c_xdr_tsr,Treatment success rate: XDR-TB cases
1680,TB_conf_mdr_tx_pct,Confirmed cases of MDR-TB started treatment for MDR-TB (%)
1681,TB_e_inc_num,Number of incident tuberculosis cases
1682,TB_e_inc_num_014,Number of incident tuberculosis cases in children aged 0 - 14
1683,TB_e_inc_tbhiv_100k,Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)
1684,TB_e_inc_tbhiv_num,"Number of incident tuberculosis cases,  (HIV-positive cases)"
1685,TB_e_mdr_num,Estimated MDR-TB cases among notified pulmonary TB cases
1686,TB_e_mort_exc_tbhiv_num,"Number of deaths due to tuberculosis, excluding HIV"
1687,TB_e_prev_num,Number of prevalent tuberculosis cases
1688,TB_effective_treatment_coverage,Tuberculosis effective treatment coverage (%)
1689,TB_hiv_art_pct,HIV-positive TB patients on ART (antiretroviral therapy) (%)
1690,TB_hiv_cpt_pct,HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%)
1691,TB_hivtest_pct,TB patients with known HIV status (%)
1692,TB_hivtest_pos_pct,Tested TB patients HIV-positive (%)
1693,TB_mdr,Confirmed cases of MDR-TB
1694,TB_new_clindx,"New or unknown treatment history cases: Pulmonary, clinically diagnosed"
1695,TB_new_ep,New cases: extrapulmonary
1696,TB_new_labconf,"New or unknown treatment history cases: Pulmonary, bacteriologically confirmed"
1697,TB_new_oth,New cases: other
1698,TB_new_sn,New cases: pulmonary smear-negative
1699,TB_new_snsuoth,"New cases: Pulmonary, smear-negative/unknown/not done and other new cases"
1700,TB_new_sp,"New cases: Pulmonary, smear-positive"
1701,TB_new_su,New cases: pulmonary smear unknown/not done
1702,TB_newret_oth,Treatment history unknown
1703,TB_ret_nrel,"Previously treated  cases, excluding relapse"
1704,TB_ret_oth,Retreatment cases: other
1705,TB_ret_rel,Relapse cases (pre-2013 definition)
1706,TB_ret_rel_clindx,"Relapse cases: Pulmonary, clinically diagnosed"
1707,TB_ret_rel_ep,Relapse cases: extrapulmonary
1708,TB_ret_rel_labconf,"Relapse cases: Pulmonary, bacteriologically confirmed"
1709,TB_ret_tad,Retreatment cases: treatment after default (pulmonary smear and/or culture positive)
1710,TB_ret_taf,Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)
1711,TB_rr_mdr,Confirmed cases of RR-/MDR-TB
1712,TB_sldst_avail,Second-line drug susceptibility testing (DST) available
1713,TB_tot_newrel,Tuberculosis - new and relapse cases
1714,tfr,Total fertility rate (per woman)
1715,TOTENV_1,Deaths attributable to the environment
1716,TOTENV_10,Total environment  attributable DALYs per 100'000 children under 5 years
1717,TOTENV_11,Deaths attributable to the environment in children under 5 years (%)
1718,TOTENV_12,DALYs attributable to the environment in children under 5 years (%)
1719,TOTENV_2,Age-standardized deaths attributable to the environment (per 100 000 population)
1720,TOTENV_3,Disability-adjusted life years (DALYs) attributable to the environment
1721,TOTENV_4,Age-standardized DALYs attributable to the environment (per 100 000 population)
1722,TOTENV_5,Deaths attributable to the environment (%)
1723,TOTENV_6,Disability-adjusted life years (DALYs) attributable to the environment (%)
1724,TOTENV_7,Total environment attributable deaths ('000) in children under 5 years
1725,TOTENV_8,Total environment  attributable deaths per 100'000 children under 5 years
1726,TOTENV_9,Total environment attributable DALYs ('000) in children under 5 years
1727,u5mr,Under-five mortality rate (deaths per 1000 live births)
1728,UHC_AVAILABILITY_SCORE,Primary data availability for UHC Service Coverage Index (SDG 3.8.1) (%)
1729,UHC_IHR,Compliance with international health regulations
1730,UHC_INDEX_REPORTED,UHC Service Coverage Index (SDG 3.8.1)
1731,UHC_SCI_CAPACITY,UHC Service Coverage sub-index on service capacity and access
1732,UHC_SCI_INFECT,UHC Service Coverage sub-index on infectious diseases
1733,UHC_SCI_NCD,UHC Service Coverage sub-index on noncommunicable diseases
1734,UHC_SCI_RMNCH,"UHC Service Coverage sub-index on reproductive, maternal, newborn and child health"
1735,UNICEF_ORS,Children aged <5 years with diarrhoea receiving ORS (%)
1736,UNICEF_PNCMOTHER,Women age 15-49 years who received a health check within 2 days after delivery of their most recent live birth in the last 2 years (%)
1737,UNICEF_PNCNEWBORN,Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%)
1738,UV_1,UV radiation
1739,UV_2,UV radiation attributable deaths
1740,UV_3,UV radiation attributable DALYs ('000)
1741,UV_4,UV radiation attributable deaths per 100'000 capita
1742,UV_5,UV radiation attributable DALYs per 100'000 capita
1743,VIOLENCE_CHILD_EMOTIONAL,Lifetime prevalence of child emotional abuse (%)
1744,VIOLENCE_CHILD_NEGLECT,Lifetime prevalence of child physical neglect (%)
1745,VIOLENCE_CHILD_PHYSICAL,Lifetime prevalence of child physical abuse (%)
1746,VIOLENCE_CHILD_SEXUAL,Lifetime prevalence of child sexual abuse (%)
1747,VIOLENCE_EXTENTIMP_ALLTYPES,Extent of implementation of  mental health services for victims of all types of violence
1748,VIOLENCE_EXTENTIMP_CHILDHOMEVISIT,Child maltreatment: Extent of implementation of home-visiting programmes
1749,VIOLENCE_EXTENTIMP_CHILDPROTECTION,Extent of implementation of child protection services
1750,VIOLENCE_EXTENTIMP_ELDERCAREGIVER,Elder abuse: Extent of implementation  of caregiver-support programmes
1751,VIOLENCE_EXTENTIMP_PARTNERVIOLPREVENTION,Intimate partner violence: Extent of implementation  of dating violence prevention programmes
1752,VIOLENCE_EXTENTIMP_VICTIMSMEDICOLEGAL,Extent of implementation of medico-legal services for victims of sexual violence
1753,VIOLENCE_EXTENTIMP_YOUTHLIFESKILLS,Youth violence: Extent of implementation of life-skills and social development programmes
1754,VIOLENCE_HOMICIDENUM,Estimates of number of homicides
1755,VIOLENCE_HOMICIDERATE,Estimates of rates of homicides per 100 000 population
1756,vita,Children aged 6-59 months who received vitamin A supplementation (%)
1757,W_Group,Warning about the dangers of tobacco
1758,W1_HW_law_A,Law mandates that health warnings appear on tobacco packages
1759,W1_HW_law_B,Law mandates that health warnings appear on other smoked tobacco packages
1760,W1_HW_law_C,Law mandates that health warnings appear on smokeless tobacco packages
1761,W10_graphic_A,Do the health warnings on cigarette packaging include a photograph or graphic?
1762,W10_graphic_B,Do the health warnings on other smoked tobacco packaging include a photograph or graphic?
1763,W10_graphic_C,Do the health warnings on smokeless tobacco packaging include a photograph or graphic?
1764,W11_outside_pack_A,Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale?
1765,W11_outside_pack_B,Do health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale?
1766,W11_outside_pack_C,Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale?
1767,W12_imports_dutyfree_A,Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
1768,W12_imports_dutyfree_B,Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
1769,W12_imports_dutyfree_C,Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
1770,W13_ind_liability_A,Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
1771,W13_ind_liability_B,Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry
1772,W13_ind_liability_C,Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
1773,W14_harm_effects_A,Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health?
1774,W14_harm_effects_B,Do health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health?
1775,W14_harm_effects_C,Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health?
1776,W15_specific_hw_A,Does the law mandate specific health warnings on cigarette packaging?
1777,W15_specific_hw_B,Does the law mandate specific health warnings on other smoked tobacco packaging?
1778,W15_specific_hw_C,Does the law mandate specific health warnings on smokeless tobacco packaging?
1779,W16_number_hw_A,How many health warnings are approved by the law for cigarette packaging?
1780,W16_number_hw_B,How many health warnings are approved by the law for other smoked tobacco packaging?
1781,W16_number_hw_C,How many health warnings are approved by the law for smokeless tobacco packaging?
1782,W17_fines_A,Health warnings on cigarette packaging law requires or establishes fines for violations
1783,W17_fines_B,Health warnings on other smoked tobacco packaging law requires or establishes fines for violations
1784,W17_fines_C,Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
1785,W18_misleading_terms_A,Ban on deceitful terms on cigarette packaging
1786,W18_misleading_terms_B,Ban on deceitful terms on other smoked tobacco packaging
1787,W18_misleading_terms_C,Ban on deceitful terms on smokeless tobacco packaging
1788,W19_colours_numbers_A,Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
1789,W19_colours_numbers_B,Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
1790,W19_colours_numbers_C,Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
1791,W2_pc_front_back_A,Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
1792,W2_pc_front_back_B,Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging
1793,W2_pc_front_back_C,Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
1794,W20_flavours_A,Cigarette packaging and labelling must not use descriptors depicting flavours
1795,W20_flavours_B,Other smoked tobacco packaging and labelling must not use descriptors depicting flavours
1796,W20_flavours_C,Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
1797,W21_emissions_A,Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
1798,W21_emissions_quant_B,Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
1799,W23_emissions_front_back_A,Cigarette packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas
1800,W21_emissions_quant_C,Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
1801,W22_emissions_qual_A,Cigarette packaging and labelling must display qualitative information on relevant constituents and emissions
1802,W22_emissions_qual_B,Other smoked tobacco packaging and labelling must display qualitative information on relevant constituents and emissions
1803,W22_emissions_qual_C,Smokeless tobacco packaging and labelling must display qualitative information on relevant constituents and emissions
1804,W23_emissions_front_back_B,Other smoked tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas
1805,W23_emissions_front_back_C,Smokeless tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas
1806,W24_exp_date_A,Cigarette packaging and labelling must not display expiry dates
1807,W24_exp_date_B,Other smoked tobacco packaging and labelling must not display expiry dates
1808,W24_exp_date_C,Smokeless tobacco packaging and labelling must not display expiry dates
1809,W25_quitline_number_A,The quit line number must appear on cigarette packaging or labelling
1810,W25_quitline_number_B,The quit line number must appear on other smoked tobacco packaging or labelling
1811,W25_quitline_number_C,The quit line number must appear on smokeless tobacco packaging or labelling
1812,W26_plain_packaging_A,Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
1813,W26_plain_packaging_B,Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
1814,W26_plain_packaging_C,Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited).
1815,W27_smokeless_prod_ban,The sale of all smokeless tobacco products is completely banned
1816,W3_pc_front_A,Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
1817,W3_pc_front_B,Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging
1818,W3_pc_front_C,Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
1819,W4_pc_back_A,Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
1820,W4_pc_back_B,Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging
1821,W4_pc_back_C,Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
1822,W5_top_side_A,Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
1823,W5_top_side_B,Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package
1824,W5_top_side_C,Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
1825,W6_font_A,"Does the law mandate font style, font size and colour of health warnings on cigarette packaging?"
1826,W6_font_B,"Does the law mandate font style, font size and colour of health warnings on other smoked tobacco packaging?"
1827,W6_font_C,"Does the law mandate font style, font size and colour of health warnings on smokeless tobacco packaging?"
1828,W7_rotation_A,Are the health warnings on cigarette packaging rotating?
1829,W7_rotation_B,Are the health warnings on other smoked tobacco packaging rotating?
1830,W7_rotation_C,Are the health warnings on smokeless tobacco packaging rotating?
1831,W8_princ_langs_A,Are the health warnings on cigarette packaging written in the principal language(s) of the country?
1832,W8_princ_langs_B,Are the health warnings on other smoked tobacco packaging written in the principal language(s) of the country?
1833,W8_princ_langs_C,Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country?
1834,W9_no_obscure_A,Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
1835,W9_no_obscure_B,Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps
1836,W9_no_obscure_C,Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
1837,wast5,Wasting prevalence in children aged < 5 years (%)
1838,WHOSIS_000001,Life expectancy at birth (years)
1839,WHOSIS_000002,Healthy life expectancy (HALE) at birth (years)
1840,WHOSIS_000003,Neonatal mortality rate (per 1000 live births)
1841,WHOSIS_000004,Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
1842,WHOSIS_000006,Infants exclusively breastfed for the first six months of life (%)
1843,WHOSIS_000007,Healthy life expectancy (HALE) at age 60 (years)
1844,WHOSIS_000014,Stillbirth rate (per 1000 total births)
1845,WHOSIS_000015,Life expectancy at age 60 (years)
1846,WHS_PBR,Preterm birth rate (per 100 live births)
1847,WHS10_8,Civil registration coverage of cause-of-death (%)
1848,WHS10_9,Ill-defined causes in cause-of-death registration (%)
1849,WHS2_126,Distribution of years of life lost by major cause group
1850,WHS2_131,Age-standardized NCD mortality rate  (per 100 000 population)
1851,WHS2_138,Deaths due to HIV/AIDS (per 100 000 population)
1852,WHS2_152,Deaths due to malaria (per 100 000 population)
1853,WHS2_160,Age-standardized mortality rate by cause (per 100 000 population) - Cancer
1854,WHS2_161,Age-standardized mortality rate by cause (per 100 000 population) - Cardiovascular
1855,WHS2_174,Distribution of years of life lost by broader causes (%) - Injuries
1856,WHS3_41,Diphtheria - number of reported cases
1857,WHS3_42,Japanese encephalitis - number of reported cases
1858,WHS3_43,Pertussis - number of reported cases
1859,WHS3_45,Number of new leprosy cases
1860,WHS3_46,Total tetanus - number of reported cases
1861,WHS3_49,Poliomyelitis - number of reported cases
1862,WHS3_50,Yellow fever - number of reported cases
1863,WHS3_522,Number of reported cases of tuberculosis
1864,WHS3_53,Mumps - number of reported cases
1865,WHS3_55,Congenital Rubella Syndrome - number of reported cases
1866,WHS3_56,Neonatal tetanus - number of reported cases
1867,WHS3_57,Rubella - number of reported cases
1868,WHS3_62,Measles - number of reported cases
1869,WHS4_100,Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
1870,WHS4_106,Children aged < 5 years with pneumonia symptoms taken to a healthcare provider (%)
1871,WHS4_111,Antenatal care coverage - at least one visit (%)
1872,WHS4_111_AGE1519,"Antenatal care coverage - at least one visit, among girls aged 15-19 (%)"
1873,WHS4_115,Births by caesarean section (%)
1874,WHS4_117,Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
1875,WHS4_128,Neonates protected at birth against neonatal tetanus (PAB) (%)
1876,WHS4_129,Hib (Hib3) immunization coverage among 1-year-olds (%)
1877,WHS4_154,Antenatal care coverage - at least four visits (%)
1878,WHS4_543,BCG immunization coverage among 1-year-olds (%)
1879,WHS4_544,Polio (Pol3) immunization coverage among 1-year-olds (%)
1880,WHS5_512,Population using solid fuels (%)
1881,WHS6_100,Radiotherapy units (per 1 000 000 population)
1882,WHS6_101,Median availability of selected generic medicines (%) - Private
1883,WHS6_102,Hospital beds (per 10 000 population)
1884,WHS6_116,Median consumer price ratio of selected generic medicines - Private
1885,WHS8_110,Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
1886,W-MM_Group,Anti-tobacco mass media campaigns
1887,WSH_1,SDG 3.9.2 WASH deaths
1888,WSH_10,"Number of diarrhoea deaths from inadequate water, sanitation and hygiene"
1889,WSH_10_HYG,Number of diarrhoea deaths from inadequate hygiene
1890,WSH_10_SAN,Number of diarrhoea deaths from inadequate sanitation
1891,WSH_10_WAT,Number of diarrhoea deaths from inadequate water
1892,WSH_2,"Water, sanitation and hygiene attributable deaths ('000) in children under 5 years"
1893,WSH_20,"Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene"
1894,WSH_20_HYG,Attributable fraction of diarrhoea to inadequate hygiene
1895,WSH_20_SAN,Attributable fraction of diarrhoea to inadequate sanitation
1896,WSH_20_WAT,Attributable fraction of diarrhoea to inadequate water
1897,WSH_3,"Water, sanitation and hygiene attributable deaths per 100'000 capita"
1898,WSH_30,"Number of diarrhoea DALYs from inadequate water, sanitation and hygiene"
1899,WSH_30_HYG,Number of diarrhoea DALYs from inadequate hygiene
1900,WSH_30_SAN,Number of diarrhoea DALYs from inadequate sanitation
1901,WSH_30_WAT,Number of diarrhoea DALYs from inadequate water
1902,WSH_4,"Water, sanitation and hygiene  attributable deaths per 100'000 children under 5 years"
1903,WSH_5,"Water, sanitation and hygiene attributable DALYs ('000)"
1904,WSH_6,"Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years"
1905,WSH_7,"Water, sanitation and hygiene attributable DALYs per 100'000 capita"
1906,WSH_8,"Water, sanitation and hygiene  attributable DALYs per 100'000 children under 5 years"
1907,WSH_HYGIENE_BASIC,Population with basic handwashing facilities at home (%)
1908,WSH_SANITATION_BASIC,Population using at least basic sanitation services (%)
1909,WSH_SANITATION_OD,Population practising open defecation (%)
1910,WSH_SANITATION_SAFELY_MANAGED,Population using safely managed sanitation services (%)
1911,WSH_WATER_BASIC,Population using at least basic drinking-water services (%)
1912,WSH_WATER_SAFELY_MANAGED,Population using safely managed drinking-water services (%)
1913,NCD_CCS_ARB,General availability of Angiotensin II receptor blockers (ARBs) in the public health sector
1914,NCD_CCS_CRD_GUIDE,Existence of evidence-based national guidelines/protocols/standards for the management of chronic respiratory diseases
1915,NCD_CCS_MORT_TARGET,Existence of a national target on NCD mortality
1916,IHRSPAR_CAPACITY01,Legislation and Financing
1917,bfearly,Early initiation of breastfeeding (in the two years preceding the survey) (%)
1918,R_Price_lowest_cost_ppp,Cheapest brand of cigarettes - price in PPP$
1919,ASSISTIVETECH_SOURCESOFAT,Sources of assistive products (%)
1920,MALARIA_PF_INDIG,Number of indigenous P. falciparum malaria cases
1921,O_Cytisine_sold,Cytisine - legally sold
1922,NCD_CCS_PA_POL_WORK,Existence of policy promoting physical activity: workplace initiatives
1923,FINPROTECTION_IMP_BNLFHU_FURIMP_HH,"Households further impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities) (%)"
1924,IHRSPAR_CAPACITY13,Radiation Emergencies
1925,PHE_HHAIR_POP_CATEGORY_FUELS,"Population with primary reliance on fuels and technologies)for cooking, by fuel type (in millions)"
1926,Yth_curr_cig_smoking,Prevalence of current cigarette smoking among adolescents (%)
1927,NCD_CCS_ESS_MEDS_TECH_TARGET,Existence of a national target on essential medicines and technologies
1928,MALARIA_IMPORTED,Number of imported malaria cases
1929,R_earmarking,Reported use of earmarked tobacco taxes
1930,IHRSPAR_CAPACITY03,Zoonotic Events and the Human-animal Interface
1931,IHRSPAR_CAPACITY07,Human Resources (SPAR)
1932,PHE_HHAIR_POP_POLLUTING_FUELS,Population with primary reliance on polluting fuels and technologies for cooking (in millions)
1933,IHRSPAR_CAPACITY06,Surveillance (SPAR)
1934,MALARIA_ITN_COVERAGE,"Population with access to an insecticide-treated bed net (ITN) for malaria protection (%), modelled"
1935,Adult_curr_smokeless,Prevalence of current smokeless tobacco use among adults (%)
1936,Yth_nonsmoked_svy_title,Name of latest youth prevalence survey (nonsmoked)
1937,RADON_Q501_1,Reference level for dwellings (Bq/m3)
1938,CARE_SOURCE,Care-seeking by type of patient and source of care (%)
1939,E_compl_e10,Compliance with ban on promotional discounts (score)
1940,NCD_CCS_TOB_SVY,"Has conducted a recent, national adult risk factor survey covering tobacco use"
1941,Adult_nonsmoked_national,Representation of latest adult prevalence survey (nonsmoked)
1942,Yth_nonsmoked_svy_yr,Year of latest youth prevalence survey (nonsmoked)
1943,E_compl_e14,Compliance with ban on appearance of tobacco products in TV and/or films (score)
1944,FINPROTECTION_IMP_P310_LEVEL_MILLION,Total population pushed  further below the $3.20 a day poverty line by household health expenditures (millions)
1945,NCD_CCS_PA_GUIDELINES_OLDADULTS,Existence of national guidelines for physical activity for older adults
1946,P_compl_p1,Compliance with smoke-free health-care facilities law (score)
1947,RADON_Q503,Existence of national reference level for workplaces
1948,NCD_CCS_ALC_TARGET,Existence of a national target on alcohol
1949,NCD_CCS_PA_SVY,"Has conducted a recent, national adult risk factor survey covering physical inactivity"
1950,NCD_CCS_PA_POL_WALKBIKE,Existence of policy promoting physical activity: walking and cycling
1951,MALARIA_EST_DEATHS,Estimated number of malaria deaths
1952,FINPROTECTION_IMP_P310_POP,Population pushed further below the $3.20 a day poverty line by household health expenditures (%)
1953,R_Price_mp_estimate_ppp,Most sold brand of cigarettes - price in PPP$
1954,P_compl_p4,Compliance with smoke-free government facilities law (score)
1955,W21_emissions_quant_A,Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
1956,WHOSIS_000016,Mortality rate among children ages 5 to 9 years (per 1000 children aged 5)
1957,MALARIA_EST_INCIDENCE,Estimated malaria incidence (per 1000 population at risk)
1958,IHRSPAR_CAPACITY10,Risk Communication (SPAR)
1959,E23_vending_machines,Ban on tobacco vending machines
1960,E22_subnational_authority_exists,"Subnational bans on tobacco advertising, promotion and sponsorship authority exists"
1961,AIR_71,Ambient air pollution attributable DALYs in children under 15 years
1962,ASSISTIVETECH_Q06,Workforce availability for assistive technology
1963,SDGIPV,Proportion of ever-partnered women and girls aged 15-49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
1964,SDGHEALTHFACILITIESESSENTIALMEDS,Proportion of health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis
1965,NCD_CCS_bone_marrow,General availability of bone marrow transplantation in the public health system
1966,RADON_Q502_1,Reference level for buildings with high public occupancy (Bq/m3)
1967,NCD_CCS_CHOL_SVY,"Has conducted a recent, national adult risk factor survey covering raised total cholesterol"
1968,NCD_CCS_DRUG_THERAPY_TARGET,Existence of a national target on drug therapy and counselling
1969,IHRSPAR_CAPACITY11,Points of Entry (SPAR)
1970,NCD_CCS_PBCR,Existence of population-based cancer registry
1971,HEMOGLOBINLEVEL_CHILDREN_MEAN,Mean hemoglobin level of children aged 6-59 months
1972,Adult_nonsmoked_age_grp,Age range of latest adult prevalence survey (nonsmoked)
1973,GASPRP,Reporting countries
1974,TB_e_inc_rr_num,Estimated number of MDR/RR-TB incident cases
1975,R_Price_lowest_cost_estimate,Cheapest brand of cigarettes - price in currency reported
1976,NCD_HYP_DIAGNOSIS_A,"Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, age-standardized"
1977,Yth_daily_smokeless,Prevalence of daily smokeless tobacco use among adolescents (%)
1978,ASSISTIVETECH_Q07,Availability of education/training for assistive technology
1979,E_compl_e_all_indir,Overall compliance with bans on promotion and sponsorship (score)
1980,HEMOGLOBINLEVEL_PREGNANT_MEAN,Mean hemoglobin level of pregnant women (aged 15-49 years)
1981,ASSISTIVETECH_Q08,Existence of financial mechanisms for assistive technology
1982,RADON_Q202,Existence of any subnational radon activity
1983,cpmowho,Contraceptive prevalence - use of modern methods (%)
1984,NCD_CHOL_MEANHDL_A,"Mean HDL cholesterol, age-standardized"
1985,E_compl_all_dir,Overall compliance with bans on direct advertising (score)
1986,Adult_svy_national,Representativeness of most recent survey of adults
1987,IHRSPAR_CAPACITY02,IHR Coordination and National IHR Focal Point Functions
1988,MALARIA_MICR_TEST,Number of malaria suspects examined by microscopy
1989,MALARIA_EST_CASES,Estimated number of malaria cases
1990,P_compl_p5,Compliance with smoke-free indoor offices law (score)
1991,IHRSPAR_CAPACITY12,Chemical Events
1992,Adult_curr_e-cig,Prevalence of current e-cigarette use among adults (%)
1993,FINPROTECTION_IMP_PRELPL_POP,Population pushed further  below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
1994,IHRSPAR_CAPACITY05,Laboratory (SPAR)
1995,MALARIA_SUSPECTS,Number of suspected malaria cases
1996,SDGIPVLT,Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime
1997,NCD_HYP_PREVALENCE_A,"Prevalence of hypertension among adults aged 30-79 years, age-standardized"
1998,IHRSPAR_CAPACITY08,National Health Emergency Framework
1999,NCD_HYP_PREVALENCE_C,"Prevalence of hypertension among adults aged 30-79 years, crude"
2000,O_Cytisine_where,Cytisine - place available
2001,GLASSAMC_GPW13_T4B,Target ≥60% of total antibiotic consumption being Access group antibiotics (GPW13 target 4b)
2002,vbcg,BCG immunization coverage among one-year-olds (%)
2003,SDGIPV12M,Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
2004,NCD_CCS_TEL_HYDRO_COMBO,General availability of Fixed dose combination avail (telmisartan + hydrochlorothiazide) in the public health sector
2005,MALARIA_INDIG_STATUS,Status of indigenous malaria cases
2006,NCD_CCS_FOOD_TAX,"Existence of tax on foods high in fat, sugars or salt"
2007,MH_27,Publication year of the policy or plan (latest revision)
2008,HIV_0000000028,"Estimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 population"
2009,NCD_CCS_EyePlan,Existence of operational policy/strategy/action plan for eye health
2010,NCD_HYP_CONTROL_A,"Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, age-standardized"
2011,MALARIA_PV_INDIG,Number of indigenous P. vivax malaria cases
2012,AMR_INFECT_MRSA,"Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA), median (%)"
2013,NCD_CCS_PA_GUIDELINES_5to19,Existence of national guidelines for physical activity for children and adolescents aged 5-19
2014,IMMUNIZATION_VACCINATIONCARDSSEEN,Proportion of vaccination cards seen (%)
2015,GASPRSCFM,Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
2016,NCD_CCS_CANCER_GUIDE,Existence of evidence-based national guidelines/protocols/standards for the management of cancer
2017,MALARIA_INDIG,Number of indigenous malaria cases
2018,RADON_Q707,Inclusion of radon education for building professionals
2019,NCD_CCS_PA_POL_CHILDCARE,Existence of policy promoting physical activity: childcare settings
2020,ASSISTIVETECH_Q10,Existence of initiatives/collaborations on assistive technology
2021,MALARIA_CONF_CASES,Number of confirmed malaria cases
2022,E_compl_e12,Compliance with ban on indentifying non-tobacco products with tobacco brand names (score)
2023,NUTRITION_ANAEMIA_NONPREGNANT_PREV,Prevalence of anaemia in non-pregnant women (aged 15-49) (%)
2024,ASSISTIVETECH_SATISFACTIONACTIVITIES,Satisfaction with assistive products for different environments and activities (%)
2025,E_compl_e6,Compliance with ban on advertising at point of sale (score)
2026,MALARIA_RDT_TEST,Number of malaria suspects examined by rapid diagnostic test (RDT)
2027,NCD_CCS_BPmsmt,General availability of blood pressure measurement at the primary health care level
2028,NCD_CCS_BP_SVY,"Has conducted a recent, national adult risk factor survey covering raised blood pressure/hypertension"
2029,uwgt5,Underweight prevalence in children aged < 5 years (%) (Health inequality monitor)
2030,CARE_SEEK,Care-seeking by type of patient and source of care (%) (see CARE_SOURCE)
2031,NTD_BU_END,Status of endemicity of buruli ulcder
2032,P_compl_p6,Compliance with smoke-free restaurants law (score)
2033,M_Est_smk_curr,Estimate of current tobacco smoking prevalence (%)
2034,NCD_CHOL_MEANTOTALCHOL_C,"Mean total cholesterol,  crude"
2035,FINPROTECTION_IMP_BNLFHU_P_HH,"Households impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities) (%)"
2036,RADON_Q605,Authorization/accreditation required for official radon measurement providers
2037,Adult_daily_smokeless,Prevalence of daily smokeless tobacco use among adults (%)
2038,E17a_csr_ban,Ban on Corporate Social Responsibility activities (CSR)
2039,vzdpt,One-year-old children who have not received any doses of the DTP vaccine (%)
2040,NCD_CCS_ALC_MGMT_GUIDE,Existence of evidence-based national guidelines/protocols/standards for the management of alcohol use disorders
2041,ASSISTIVETECH_SATISFACTIONSERVICES,Satisfaction with assistive products and related services (%)
2042,NCD_CCS_diab_retin,General availability of diabetic retinopathy screening in the public health system
2043,ASSISTIVETECH_BARRIERAT,Barriers to accessing assistive products (%)
2044,NCD_HYP_CONTROL_C,"Prevalence of controlled hypertension among adults aged 30-79 years with hypertension, crude"
2045,E_compl_e5,Compliance with ban on billboard and outdoor advertising (score)
2046,NCD_CCS_PA_POL_PUBLIC,Existence of policy promoting physical activity: public open spaces
2047,NUTRITION_ANAEMIA_REPRODUCTIVEAGE_PREV,Prevalence of anaemia in women of reproductive age (aged 15-49) (%)
2048,HIV_0000000027,Reported number of tests performed where results were received by a person (testing volume)
2049,NCD_CCS_CVD_GUIDE,Existence of evidence-based national guidelines/protocols/standards for the management of cardiovascular diseases
2050,NCD_CCS_PA_TARGET,Existence of a national target on physical inactivity
2051,NCD_CCS_OVWT_SVY,"Has conducted a recent, national adult risk factor survey covering overweight and obesity"
2052,NCD_HYP_TREATMENT_A,"Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, age-standardized"
2053,E_compl_e3,Compliance with ban on advertising in local magazines and newspapers (score)
2054,Youth_svy_age_range,Age range of most recent adolescent survey
2055,NCD_CCS_PA_MASS_PART,Implementation of a recent mass participation event
2056,NCD_CHOL_MEANHDL_C,"Mean HDL cholesterol, crude"
2057,P_compl_p2,Compliance with smoke-free education facilities except universities law (score)
2058,Adult_survey_title,Title of most recent survey of adults
2059,RADON_Q305,Existence of national radon map
2060,FINPROTECTION_IMP_PREL_LEVEL_MILLION,Total population pushed   further  below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (millions)
2061,ASSISTIVETECH_TRAVELDISTANCEAT,Travel distance to obtain assistive products (%)
2062,SRHINSTITUTIONALBIRTH,Institutional Births (birth taken place in a facility) (%)
2063,FINPROTECTION_IMP_NPRELPL_POP,Population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
2064,NCD_CCS_TOB_MGMT_GUIDE,Existence of evidence-based national guidelines/protocols/standards for the management of tobacco dependence
2065,FAMILYPLANNINGUNPDUHC,"Women of reproductive age (15−49 years) who are married or in-union who have their need for family planning satisfied with modern methods (%), UNPD"
2066,NUTRITION_ANAEMIA_REPRODUCTIVEAGE_NUM,Number of women of reproductive age (aged 15-49 years) with anaemia (thousands)
2067,M_Est_cig_curr_std,Estimate of current cigarette smoking prevalence (%) (age-standardized rate)
2068,AMR_INFECT_ECOLI,"Proportion of bloodstream infection due Escherichia coli resistant to 3rd-generation cephalosporin, median (%)"
2069,SDGFPALL,Women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (%)
2070,E_compl_e9,Compliance with ban on free distribution in mail or through other means (score)
2071,Yth_daily_tob_smoking,Prevalence of daily tobacco smoking among adolescents (%)
2072,NCD_CCS_OBES_TARGET,Existence of a national target on obesity
2073,LBW_NUMBER,Low birth weight (in thousands)
2074,LBW_PREVALENCE,"Low birth weight, prevalence (%)"
2075,ASSISTIVETECH_TOTALNEED,Prevalence of need of assistive products (%)
2076,OHS_POLICYSTATUS,Existence of national policy instruments for occupational health and safety for health workers
2077,FINPROTECTION_IMP_P190_LEVEL_SH,Total population pushed further below the $1.90 a day poverty line by household health expenditures (%)
2078,FINPROTECTION_IMP_NP_REL_LEVEL_MILLION,Total population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (millions)
2079,AIR_73,Ambient air pollution attributable YLL in children under 15 years
2080,AMRGLASS_SURVL04,Number of surveillance sites reporting to GLASS: In- and outpatient facilities
2081,NCD_CCS_cancer_surgery,General availability of cancer surgery in the public sector
2082,FINPROTECTION_IMP_P310_LEVEL_SH,Total population pushed  further  below the $3.20 a day poverty line by household health expenditures (%)
2083,CHILDVIOL,Indicator 16.2.1: Proportion of children aged 1-17 years who experienced any physical punishment and/or psychological aggression by caregivers in the past month
2084,GASPRSESC,Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
2085,Camp_media_monitor,Process evaluation was employed to assess implementation of the campaign
2086,NCD_CCS_CANCER_DEPT,General availability of cancer centres or cancer departments at tertiary level in the public sector
2087,GASPRSCIP,Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
2088,NCD_CCS_PA_GUIDELINES_UNDER5,Existence of national guidelines for physical activity for children under 5
2089,MALARIA_ACT_TREATED,Number of malaria cases treated with artemisinin-based combination therapies (ACTs)
2090,NUTRITION_ANAEMIA_CHILDREN_NUM,Number of children aged 6–59 months with anaemia (thousands)
2091,NCD_CCS_PA_POL_COMM_BASED,Existence of policy promoting physical activity: community-based and sports initiatives
2092,VACCINEPREVENTABLE_WILDPOLIO,Number of reported cases of poliomyelitis by wild poliovirus (WPV)
2093,Adult_curr_tob_smoking,Prevalence of current tobacco smoking among adults (%)
2094,MALARIA_MICR_POS,Number of malaria positive cases by microscopy
2095,Yth_curr_smokeless,Prevalence of current smokeless tobacco use among adolescents (%)
2096,P_compl_p7,Compliance with smoke-free pubs and bars law (score)
2097,Adult_curr_cig_smoking,Prevalence of current cigarette smoking among adults (%)
2098,SDGHPVRECEIVED,Girls aged 15 years old that received the recommended doses of HPV vaccine (%)
2099,Yth_daily_cig_smoking,Prevalence of daily cigarette smoking among adolescents (%)
2100,ASSISTIVETECH_Q04,Existence of responsible ministry/authority on assistive technology
2101,GASPRSCRO,Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
2102,NCD_CCS_HearingPlan,Existence of operational policy/strategy/action plan for hearing health
2103,Yth_nonsmoked_national,Representation of latest youth prevalence survey (nonsmoked)
2104,NUTRITION_ANAEMIA_PREGNANT_NUM,Number of pregnant women (aged 15-49 years) with anaemia (thousands)
2105,SDGODAWS,Amount of water- and sanitation-related official development assistance that is part of a government-coordinated spending plan (current US$ millions)
2106,Youth_svy_yr,Year of most recent adolescent survey
2107,NCD_CCS_path_lab,General availability of pathology services (laboratories) in the public sector
2108,IHRSPAR_CAPACITY09,Health Service Provision
2109,Adult_curr_tob_use,Prevalence of current tobacco use among adults (%)
2110,ASSISTIVETECH_Q01,Existence of legislation on access to assistive technology
2111,GASPRSAZM,Proportion of isolates with resistance to azithromycin reported to WHO-GASP
2112,Yth_daily_e-cig,Prevalence of daily e-cigarette use among adolescents (%)
2113,AMRGLASS_SURVL05,Total number of surveillance sites reporting to GLASS
2114,AIR_72,Ambient air pollution attributable deaths in children under 15 years
2115,E17b_csr_promo_self,Ban on tobacco companies/the tobacco industry publicizing their CSR activities
2116,P_comprehensive_subnat,Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place
2117,FINPROTECTION_IMP_PG_RELPL_STD,"Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line (60% of median daily per capita consumption or income) (%)"
2118,NUTRITION_ANAEMIA_CHILDREN_PREV,Prevalence of anaemia in children aged 6–59 months (%)
2119,NCD_CCS_PA_MGMT_GUIDE,Existence of evidence-based national guidelines/protocols/standards for the management of physical inactivity
2120,NCD_HYP_TREATMENT_C,"Prevalence of treatment (taking medicine) for hypertension among adults aged 30-79 with hypertension, crude"
2121,NCD_CCS_TransFat,Existence of national policies on trans-fatty acid elimination
2122,E17c_csr_promo_others,Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry
2123,R_Price_lowest_cost_usd,Cheapest brand of cigarettes - price in US$ at official exchange rates
2124,NCD_CHOL_MEANNONHDL_C,"Mean Non-HDL cholesterol, crude"
2125,ASSISTIVETECH_Q02,Coverage of people in need of assistive technology by legislation
2126,E_compl_e15,Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score)
2127,E_compl_e1,Compliance with ban on advertising on national television and radio (score)
2128,O_Cytisine_ins,Cytisine - cost covered
2129,ICD11_IMPL_LVL,ICD-11 implementation progress level
2130,RADON_Q503_1,Reference level for workplaces (Bq/m3)
2131,P_compl_p8,Compliance with smoke-free public transport law (score)
2132,HWF_0026,Nursing personnel (%)
2133,NCD_CHOL_MEANTOTALCHOL_A,"Mean total cholesterol,  age-standardized"
2134,CHILDMORT_DEATHS_10TO14,Number of deaths among children ages 10 to 14 years
2135,NCD_CCS_ALC_SVY,"Has conducted a recent, national adult risk factor survey covering harmful alcohol use"
2136,MH_26,Year the law was enacted (latest revision)
2137,MALARIA_RDT_POS,Number of malaria positive cases by rapid diagnostic test (RDT)
2138,R_Price_mp_estimate_usd,Most sold brand of cigarettes - price in US$ at official exchange rates
2139,FINPROTECTION_IMP_P190_LEVEL_MILLION,Total population pushed  further below the $1.90 a day poverty line by household health expenditures (millions)
2140,PHE_HHAIR_PROP_POP_POLLUTING_FUELS,Proportion of population with primary reliance on polluting fuels and technologies for cooking (%)
2141,NCD_CCS_DIET_AWARE,Implementation of a nutrition public awareness program
2142,R_admin_tax_stamps_cig,"Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes"
2143,NCD_CCS_TOB_TARGET,Existence of a national target on tobacco
2144,FINPROTECTION_IMP_BNLFHU_TOT_HH,"Households pushed below or further below a relative poverty line (reflecting basic needs: food, housing, utilities) by out-of-pocket payments (%)"
2145,NCD_HYP_DIAGNOSIS_C,"Prevalence of previous diagnosis of hypertension among adults aged 30-79 with hypertension, crude"
2146,E_compl_e13,Compliance with ban on appearance of tobacco brands in TV and/or films (score)
2147,NCD_CCS_LIS_AML_COMBO,General availability of Fixed dose combination avail (lisinopril + amlodipine) in the public health sector
2148,MALARIA_1STLINE_TREATED,Number of malaria cases treated with any first  line tx courses (including artemisinin-based combination therapies (ACTs))
2149,HEMOGLOBINLEVEL_REPRODUCTIVEAGE_MEAN,Mean hemoglobin level of women of reproductive age (aged 15-49 years)
2150,NCD_CCS_DIAB_SVY,"Has conducted a recent, national adult risk factor survey covering raised blood glucose/diabetes"
2151,NCD_CCS_PA_POL_AGEING,Existence of policy promoting physical activity: active ageing
2152,CM_04,Number of deaths among children ages 5 to 9 years
2153,Adult_nonsmoked_svy_title,Name of latest adult prevalence survey (nonsmoked)
2154,NCD_CCS_PA_TAX,Existence of tax incentives to promote physical activity
2155,WSH_DOMESTIC_WASTE_SAFELY_TREATED,SDG 6.3.1 Proportion of safely treated domestic wastewater flows (%)
2156,ASSISTIVETECH_Q05,Availability of government/registered services for assistive technology
2157,NTD_YAWSNUM_CONF,Number of confirmed yaws cases reported
2158,GLASSAMC_TC,Total consumption of antibacterials expressed as DDD per 1000 inhabitants per day
2159,vfull,Full immunization coverage among one-year-olds (%)
2160,FINPROTECTION_IMP_P190_POP,Population pushed further below the $1.90 a day poverty line by household health expenditures (%)
2161,PHE_HHAIR_POP_CLEAN_FUELS,Population with primary reliance on clean fuels and technologies for cooking (in millions)
2162,NCD_CCS_radio,General availability of radiotherapy in the public sector
2163,NCD_CCS_dilated_fundus,General availability of dilated fundus examination at the primary health care level
2164,HWF_0025,Medical doctors (%)
2165,MALARIA_EST_MORTALITY,Estimated malaria mortality rate (per 100 000 population)
2166,Yth_curr_tob_use,Prevalence of current tobacco use among adolescents (%)
2167,R_afford_cat,"Affordability – category of change 2010-2020 (Yes (less affordable), No (more affordable), No change)."
2168,Yth_nonsmoked_age_grp,Age range of latest youth prevalence survey (nonsmoked)
2169,NCD_CCS_SALT_TARGET,Existence of a national target on salt
2170,bmi30wm,"Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%)"
2171,sevwast5,Severe wasting prevalence in children aged < 5 years (%)
2172,NCD_CCS_BP_TARGET,Existence of a national target on blood pressure / hypertension
2173,CHILDMORT_MORTALITY_10TO14,Mortality rate among children ages 10 to 14 years (per 1000 children aged 10)
2174,ASSISTIVETECH_Q03,Availability of public funding for assistive technology
2175,ASSISTIVETECH_PAYERSAT,Funding for assistive products (%)
2176,Adult_svy_yr,Year of most recent survey of adults
2177,GASPTICIP,Number of isolates tested for ciprofloxacin
2178,Yth_curr_tob_smoking,Prevalence of current tobacco smoking among adolescents (%)
2179,NCD_CCS_TEL_AML_COMBO,General availability of Fixed dose combination avail (telmisartan + amlodipine) in the public health sector
2180,PHE_HHAIR_PROP_POP_CLEAN_FUELS,Proportion of population with primary reliance on clean fuels and technologies for cooking (%)
2181,NCD_CCS_LIS_HYDRO_COMBO,General availability of Fixed dose combination avail (lisinopril + hydrochlorothiazide) in the public health sector
2182,R_admin_tax_stamps_other,"Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products"
2183,MALARIA_IPTP3_COVERAGE,Pregnant women attending antenatal care  at least once and receiving at least 3 doses of Intermittent Preventive Treatment of Malaria for Pregnant Women (IPTp3) (%)
2184,vmsl,Measles immunization coverage among one-year-olds (%)
2185,AIR_75,Household air pollution attributable DALYs in children under 15 years
2186,HIV_0000000029,"Reported number of tests performed where results were received by a person (testing volume), reporting period"
2187,MALARIA_PRES_CASES,Number of presumed malaria cases
2188,FINPROTECTION_IMP_NP_REL_LEVEL_SH,Total population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
2189,NCD_CCS_OvwtPlan,Existence of operational policy/strategy/action plan to reduce overweight/obesity
2190,Youth_survey_title,Title of most recent adolescent survey
2191,GLASSAMC_AWARE,Pattern of antibiotic consumption at national level (relative consumption by AWaRe classification)
2192,NCD_CCS_OBES_MGMT_GUIDE,Existence of evidence-based national guidelines/protocols/standards for the management of overweight/obesity
2193,NCD_CCS_ComboInhaler,General availability of combination budesonide formoterol inhaler in the public health sector
2194,NCD_CHOL_MEANNONHDL_A,"Mean Non-HDL cholesterol, age-standardized"
2195,NTD_YAWSNUM_SUSP,Number of suspected yaws cases reported
2196,NCD_CCS_DIAB_TARGET,Existence of a national target on diabetes
2197,NCD_CCS_DIET_SVY,"Has conducted a recent, national adult risk factor survey covering unhealthy diet"
2198,fpsmowho,Demand for family planning satisfied - use of modern methods (%)
2199,AIR_74,Household air pollution attributable deaths in children under 15 years
2200,GASPTIAZM,Number of isolates tested for azithromycin
2201,Adult_daily_cig_smoking,Prevalence of daily cigarette smoking among adults (%)
2202,NCD_CCS_SALT_SVY,"Has conducted a recent, national adult risk factor survey covering salt/sodium intake"
2203,ASSISTIVETECH_Q09,Existence of regulations/standards/guidelines/protocols on assistive technology
2204,M_Est_tob_curr_std,Estimate of current tobacco use prevalence (%) (age-standardized rate)
2205,NUTRITION_ANAEMIA_NONPREGNANT_NUM,Number of non-pregnant women (aged 15-49 years) with anaemia (thousands)
2206,FINPROTECTION_IMP_PREL_LEVEL_SH,Total population pushed  further  below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
2207,NCD_CCS_PA_GUIDELINES,Existence of national guidelines for physical activity
2208,E6a_pt_of_sale,Ban on advertising at point of sale
2209,FINPROTECTION_CATA_CTPFHU_40_HH,"Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO/Europe) (%)"
2210,NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD,Prevalence of cervical cancer screening  among women aged 30-49 years (%)
2211,Yth_curr_e-cig,Prevalence of current e-cigarette use among adolescents (%)
2212,Adult_daily_tob_smoking,Prevalence of daily tobacco smoking among adults (%)
2213,NCD_CCS_DIAB_GUIDE,Existence of evidence-based national guidelines/protocols/standards for the management of diabetes
2214,MALARIA_IRS_COVERAGE,Number of people protected from malaria by indoor residual spraying (IRS)
2215,R_admin_duty_free_banned,Ban on sale of duty-free or excise-free cigarettes
2216,Youth_svy_national,Representativeness of most recent adolescent survey
2217,NUTRITION_ANAEMIA_PREGNANT_PREV,Prevalence of anaemia in pregnant women (aged 15-49) (%)
2218,R_min_price_policy,A minimum price policy is implemented
2219,SDGIHR2018,"Average of 13 International Health Regulations core capacity scores, SPAR version, 1st edition"
2220,P_compl_p3,Compliance with smoke-free universities law (score)
2221,vpolio,Polio immunization coverage among one-year-olds (%)
2222,HEMOGLOBINLEVEL_NONPREGNANT_MEAN,Mean hemoglobin level of non-pregnant women (aged 15-49 years)
2223,E21a_direct_ad_fines,Law requires fines for violations of advertising bans
2224,PHE_HHAIR_PROP_POP_CATEGORY_FUELS,"Proportion of population with primary reliance on fuels and technologies for cooking, by fuel type (%)"
2225,E_compl_e11,Compliance with ban on use of brand name of non-tobacco product for tobacco product (score)
2226,NCD_CCS_foot_vibr,General availability of foot vibration perception by tuning fork at the primary health care level
2227,E21b_indirect_ad_fines,Law requires fines for violations of promotion and sponsorship bans
2228,IHRSPAR_CAPACITY04,Food Safety (SPAR)
2229,vdpt,DTP3 immunization coverage among one-year-olds (%)
2230,NCD_CCS_PRICE_SUBS,Existence of price subsidies for healthy foods
2231,NTD_LEPR13,New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population
2232,GASPTIESC,Number of isolates tested for extended-spectrum cephalosporins
2233,GASPTICRO,Number of isolates tested for ceftriaxone
2234,ASSISTIVETECH_USEPREVALENCE,Prevalence of use of assistive products (%)
2235,Adult_daily_tob_use,Prevalence of daily tobacco use among adults (%)
2236,Adult_svy_age_range,Age range of most recent survey of adults
2237,MALARIA_TOTAL_CASES,Total number of  malaria cases (presumed + confirmed cases)
2238,SE_PRM_PRSL_ZS,Persistence to last grade of primary (% of cohort)
2239,RADON_Q401_1,Existence of national radon action plan - Years covered
2240,M_Est_smk_curr_std,Estimate of current tobacco smoking prevalence (%) (age-standardized rate)
2241,NCD_CCS_alteplase,General availability of alteplase for acute stroke management in the public health system
2242,Adult_nonsmoked_svy_yr,Year of latest adult prevalence survey (nonsmoked)
2243,NCD_CCS_PA_GUIDELINES_ADULTS,Existence of national guidelines for physical activity for adults
2244,Adult_daily_e-cig,Prevalence of daily e-cigarette use among adults (%)
2245,P_compl_all_sfe,Overall compliance with regulations on smoke-free environments (score)
2246,GASPTICFM,Number of isolates tested for cefixime
2247,UHCTRANSFATS,Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N)
2248,NCD_CCS_urine_strips_gluc_ketone,General availability of urine strips for glucose and ketone measurement at the primary health care level
